{"transactions":[{"id":714858,"issuer":{"id":7063,"kind":"organization","name":"Boundless Bio, Inc."},"owners":[{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":1,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":2,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32074,"kind":"person","name":"NELSEN ROBERT","position":3,"cik":"0001219042","reported_name":"NELSEN ROBERT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32071,"kind":"person","name":"GILLIS STEVEN","position":4,"cik":"0001229592","reported_name":"GILLIS STEVEN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32075,"kind":"person","name":"Burow Kristina","position":5,"cik":"0001569248","reported_name":"Burow Kristina","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-06T21:44:44.000Z","date":"2026-07-01","kind":"exercise","planned":false,"acquired":false,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The stock option vested in substantially equal monthly installments over the 11 months following June 23, 2025. The final unvested portion vested on June 15, 2026, the date of the Issuer's 2026 annual meeting of stockholders."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents a cashless stock option exercise by Kristina Burow. The net proceeds of such exercise were remitted to ARCH Venture Fund IX, L.P. (ARCH IX), ARCH Venture Fund IX Overage, L.P. (ARCH IX Overage), and ARCH Venture Fund X, L.P. (AVF X Overage LP). The stock option was granted to Kristina Burow in connection with her service on the board of directors of the Issuer."}],"balance_after":0,"derivative":{"exercise_price":1.03,"expiration_date":"2035-06-22","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001012975-26-000622","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1229592/000101297526000622/form4.xml","form_type":"4"}},{"id":714857,"issuer":{"id":7063,"kind":"organization","name":"Boundless Bio, Inc."},"owners":[{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":1,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":2,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32074,"kind":"person","name":"NELSEN ROBERT","position":3,"cik":"0001219042","reported_name":"NELSEN ROBERT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32071,"kind":"person","name":"GILLIS STEVEN","position":4,"cik":"0001229592","reported_name":"GILLIS STEVEN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32075,"kind":"person","name":"Burow Kristina","position":5,"cik":"0001569248","reported_name":"Burow Kristina","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-07-06T21:44:44.000Z","date":"2026-07-01","kind":"sale","planned":false,"acquired":false,"shares":16000,"price":2.49,"value":39840.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents a cashless stock option exercise by Kristina Burow. The net proceeds of such exercise were remitted to ARCH Venture Fund IX, L.P. (ARCH IX), ARCH Venture Fund IX Overage, L.P. (ARCH IX Overage), and ARCH Venture Fund X, L.P. (AVF X Overage LP). The stock option was granted to Kristina Burow in connection with her service on the board of directors of the Issuer."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001012975-26-000622","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1229592/000101297526000622/form4.xml","form_type":"4"}},{"id":714856,"issuer":{"id":7063,"kind":"organization","name":"Boundless Bio, Inc."},"owners":[{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":1,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":2,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32074,"kind":"person","name":"NELSEN ROBERT","position":3,"cik":"0001219042","reported_name":"NELSEN ROBERT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32071,"kind":"person","name":"GILLIS STEVEN","position":4,"cik":"0001229592","reported_name":"GILLIS STEVEN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32075,"kind":"person","name":"Burow Kristina","position":5,"cik":"0001569248","reported_name":"Burow Kristina","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-07-06T21:44:44.000Z","date":"2026-07-01","kind":"exercise","planned":false,"acquired":true,"shares":16000,"price":1.03,"value":16480.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents a cashless stock option exercise by Kristina Burow. The net proceeds of such exercise were remitted to ARCH Venture Fund IX, L.P. (ARCH IX), ARCH Venture Fund IX Overage, L.P. (ARCH IX Overage), and ARCH Venture Fund X, L.P. (AVF X Overage LP). The stock option was granted to Kristina Burow in connection with her service on the board of directors of the Issuer."}],"balance_after":16000,"source":{"system":"sec-edgar","filing":"0001012975-26-000622","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1229592/000101297526000622/form4.xml","form_type":"4"}},{"id":853893,"issuer":{"id":5757,"kind":"organization","name":"Lyell Immunopharma, Inc.","symbol":"LYEL"},"owners":[{"id":35731,"kind":"person","name":"ARCH Venture Fund XIII, L.P.","position":1,"cik":"0002006772","reported_name":"ARCH Venture Fund XIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":35730,"kind":"person","name":"ARCH Venture Partners XIII, L.P.","position":2,"cik":"0002016083","reported_name":"ARCH Venture Partners XIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":35729,"kind":"person","name":"ARCH Venture Partners XIII, LLC","position":3,"cik":"0002016082","reported_name":"ARCH Venture Partners XIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":4,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32074,"kind":"person","name":"NELSEN ROBERT","position":5,"cik":"0001219042","reported_name":"NELSEN ROBERT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32075,"kind":"person","name":"Burow Kristina","position":6,"cik":"0001569248","reported_name":"Burow Kristina","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32071,"kind":"person","name":"GILLIS STEVEN","position":7,"cik":"0001229592","reported_name":"GILLIS STEVEN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":20890,"kind":"person","name":"BERNS PAUL L","position":8,"cik":"0001202769","reported_name":"BERNS PAUL L","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":9,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-03-09T20:34:54.000Z","date":"2026-03-06","kind":"purchase","planned":false,"acquired":true,"shares":488090,"price":25.61,"value":12499984.9,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are directly held by ARCH Venture Fund XIII, L.P. (\"ARCH XIII\"). ARCH Venture Partners XIII, L.P. (\"AVP XIII LP\") is the general partner of ARCH XIII. ARCH Venture Partners XIII, LLC (\"AVP XIII LLC\") is the general partner of AVP XIII LP.  Keith Crandell, Robert Nelsen, Kristina Burow, Paul Berns and Steven Gillis are members of the investment committee of AVP XIII LLC (the \"AVP XIII LLC Committee Members\"). Each of AVP XIII LP and AVP XIII LLC may be deemed to beneficially own the shares held by ARCH XIII, and each of the AVP XIII LLC Committee Members may be deemed to share the power to direct the disposition and vote of the shares held by ARCH XIII. Each of AVP XIII LP, AVP XIII LLC and the AVP XIII LLC Committee Members disclaims beneficial ownership except to the extent of their pecuniary interest therein, if any."}],"balance_after":1426528,"source":{"system":"sec-edgar","filing":"0001012975-26-000234","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2016082/000101297526000234/form4.xml","form_type":"4"}},{"id":1012114,"issuer":{"id":6115,"kind":"organization","name":"Neumora Therapeutics, Inc."},"owners":[{"id":50020,"kind":"organization","name":"ARCH Venture Partners XII, LLC","position":1,"cik":"0001979548","reported_name":"ARCH Venture Partners XII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50021,"kind":"organization","name":"ARCH Venture Partners XII, L.P.","position":2,"cik":"0001979765","reported_name":"ARCH Venture Partners XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50022,"kind":"organization","name":"ARCH Venture Fund XII, L.P.","position":3,"cik":"0001906837","reported_name":"ARCH Venture Fund XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":4,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32071,"kind":"person","name":"GILLIS STEVEN","position":5,"cik":"0001229592","reported_name":"GILLIS STEVEN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32074,"kind":"person","name":"NELSEN ROBERT","position":6,"cik":"0001219042","reported_name":"NELSEN ROBERT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-10-29T23:21:13.000Z","date":"2025-10-27","kind":"purchase","planned":false,"acquired":true,"shares":1915700,"price":2.61,"value":4999977.0,"ownership":{"direct":false,"nature":"By ARCH Venture Fund XII, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents shares held directly by ARCH Venture Fund XII, L.P. (ARCH XII). ARCH Venture Partners XII, L.P. (AVP XII LP) is the general partner of ARCH XII. ARCH Venture Partners XII, LLC (AVP XII LLC) is the general partner of AVP XII LP.  Keith Crandell, Kristina Burow, Steven Gillis and Robert Nelsen comprise the investment committee of AVP XII LLC (the AVP XII LLC Committee Members). Each of AVP XII LP and AVP XII LLC may be deemed to beneficially own the shares held by ARCH XII, and each of the AVP XII LLC Committee Members may be deemed to share the power to direct the disposition and vote of the shares held by ARCH XII. Each of AVP XII LP, AVP XII LLC and the AVP XII LLC Committee Members disclaims beneficial ownership except to the extent of their pecuniary interest therein, if any."}],"balance_after":6046907,"source":{"system":"sec-edgar","filing":"0001012975-25-000680","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1885522/000101297525000680/form4.xml","form_type":"4"}},{"id":1547695,"issuer":{"id":7063,"kind":"organization","name":"Boundless Bio, Inc."},"owners":[{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":1,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":2,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32074,"kind":"person","name":"NELSEN ROBERT","position":3,"cik":"0001219042","reported_name":"NELSEN ROBERT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32071,"kind":"person","name":"GILLIS STEVEN","position":4,"cik":"0001229592","reported_name":"GILLIS STEVEN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2024-04-04T20:30:41.000Z","date":"2024-04-02","kind":"exercise","planned":false,"acquired":false,"shares":366301,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Represents shares held directly by ARCH Venture Fund X Overage, L.P. (ARCH X Overage).  ARCH Venture Partners X Overage, L.P. (AVP X Overage LP) is the sole general partner of ARCH X Overage."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"ARCH Venture Partners X, LLC (AVP X LLC) is the sole general partner of AVP X Overage LP. Keith Crandell, Robert Nelsen and Steven Gillis are members of the investment committee of AVP X LLC (the AVP X Committee Members). AVP X Overage LP may be deemed to beneficially own the shares held by ARCH X Overage, AVP X LLC may be deemed to beneficially own the shares held by ARCH X Overage, and each of the AVP X Committee Members may be deemed to share the power to direct the disposition and vote of the shares held by ARCH X Overage. AVP X Overage LP, AVP X LLC, and the AVP X Committee Members each disclaim beneficial ownership except to the extent of any pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":366301},"source":{"system":"sec-edgar","filing":"0000950170-24-041842","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1229592/000095017024041842/ownership.xml","form_type":"4"}},{"id":1547694,"issuer":{"id":7063,"kind":"organization","name":"Boundless Bio, Inc."},"owners":[{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":1,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":2,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32074,"kind":"person","name":"NELSEN ROBERT","position":3,"cik":"0001219042","reported_name":"NELSEN ROBERT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32071,"kind":"person","name":"GILLIS STEVEN","position":4,"cik":"0001229592","reported_name":"GILLIS STEVEN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2024-04-04T20:30:41.000Z","date":"2024-04-02","kind":"exercise","planned":false,"acquired":false,"shares":201465,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents shares held directly by ARCH Venture Fund IX Overage, L.P. (ARCH IX Overage).  ARCH Venture Partners IX Overage, L.P. (AVP IX Overage LP) is the sole general partner of ARCH IX Overage."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"ARCH Venture Partners IX, LLC (AVP IX LLC) is the sole general partner of each of AVP IX LP and AVP IX Overage LP. Keith Crandell, Robert Nelsen and Clinton Bybee are managing directors of AVP IX LLC (the AVP IX MDs). AVP IX LP and AVP IX Overage LP may be deemed to beneficially own the shares held by ARCH IX and ARCH IX Overage, respectively, AVP IX LLC may be deemed to beneficially own the shares held by ARCH IX and ARCH IX Overage, and each of the AVP IX MDs may be deemed to share the power to direct the disposition and vote of the shares held by ARCH IX and ARCH IX Overage. AVP IX LP, AVP IX Overage LP, AVP IX LLC, and the AVP IX MDs each disclaim beneficial ownership except to to the extent of any pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":201465},"source":{"system":"sec-edgar","filing":"0000950170-24-041842","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1229592/000095017024041842/ownership.xml","form_type":"4"}},{"id":1547693,"issuer":{"id":7063,"kind":"organization","name":"Boundless Bio, Inc."},"owners":[{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":1,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":2,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32074,"kind":"person","name":"NELSEN ROBERT","position":3,"cik":"0001219042","reported_name":"NELSEN ROBERT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32071,"kind":"person","name":"GILLIS STEVEN","position":4,"cik":"0001229592","reported_name":"GILLIS STEVEN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2024-04-04T20:30:41.000Z","date":"2024-04-02","kind":"exercise","planned":false,"acquired":false,"shares":164835,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents shares held directly by ARCH Venture Fund IX, L.P. (ARCH IX).  ARCH Venture Partners IX, L.P. (AVP IX LP) is the sole general partner of ARCH IX."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"ARCH Venture Partners IX, LLC (AVP IX LLC) is the sole general partner of each of AVP IX LP and AVP IX Overage LP. Keith Crandell, Robert Nelsen and Clinton Bybee are managing directors of AVP IX LLC (the AVP IX MDs). AVP IX LP and AVP IX Overage LP may be deemed to beneficially own the shares held by ARCH IX and ARCH IX Overage, respectively, AVP IX LLC may be deemed to beneficially own the shares held by ARCH IX and ARCH IX Overage, and each of the AVP IX MDs may be deemed to share the power to direct the disposition and vote of the shares held by ARCH IX and ARCH IX Overage. AVP IX LP, AVP IX Overage LP, AVP IX LLC, and the AVP IX MDs each disclaim beneficial ownership except to to the extent of any pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":164835},"source":{"system":"sec-edgar","filing":"0000950170-24-041842","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1229592/000095017024041842/ownership.xml","form_type":"4"}},{"id":1547692,"issuer":{"id":7063,"kind":"organization","name":"Boundless Bio, Inc."},"owners":[{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":1,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":2,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32074,"kind":"person","name":"NELSEN ROBERT","position":3,"cik":"0001219042","reported_name":"NELSEN ROBERT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32071,"kind":"person","name":"GILLIS STEVEN","position":4,"cik":"0001229592","reported_name":"GILLIS STEVEN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2024-04-04T20:30:41.000Z","date":"2024-04-02","kind":"exercise","planned":false,"acquired":false,"shares":227920,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Represents shares held directly by ARCH Venture Fund X Overage, L.P. (ARCH X Overage).  ARCH Venture Partners X Overage, L.P. (AVP X Overage LP) is the sole general partner of ARCH X Overage."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"ARCH Venture Partners X, LLC (AVP X LLC) is the sole general partner of AVP X Overage LP. Keith Crandell, Robert Nelsen and Steven Gillis are members of the investment committee of AVP X LLC (the AVP X Committee Members). AVP X Overage LP may be deemed to beneficially own the shares held by ARCH X Overage, AVP X LLC may be deemed to beneficially own the shares held by ARCH X Overage, and each of the AVP X Committee Members may be deemed to share the power to direct the disposition and vote of the shares held by ARCH X Overage. AVP X Overage LP, AVP X LLC, and the AVP X Committee Members each disclaim beneficial ownership except to the extent of any pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":227920},"source":{"system":"sec-edgar","filing":"0000950170-24-041842","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1229592/000095017024041842/ownership.xml","form_type":"4"}},{"id":1547691,"issuer":{"id":7063,"kind":"organization","name":"Boundless Bio, Inc."},"owners":[{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":1,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":2,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32074,"kind":"person","name":"NELSEN ROBERT","position":3,"cik":"0001219042","reported_name":"NELSEN ROBERT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32071,"kind":"person","name":"GILLIS STEVEN","position":4,"cik":"0001229592","reported_name":"GILLIS STEVEN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2024-04-04T20:30:41.000Z","date":"2024-04-02","kind":"exercise","planned":false,"acquired":false,"shares":454212,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Represents shares held directly by ARCH Venture Fund X Overage, L.P. (ARCH X Overage).  ARCH Venture Partners X Overage, L.P. (AVP X Overage LP) is the sole general partner of ARCH X Overage."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"ARCH Venture Partners X, LLC (AVP X LLC) is the sole general partner of AVP X Overage LP. Keith Crandell, Robert Nelsen and Steven Gillis are members of the investment committee of AVP X LLC (the AVP X Committee Members). AVP X Overage LP may be deemed to beneficially own the shares held by ARCH X Overage, AVP X LLC may be deemed to beneficially own the shares held by ARCH X Overage, and each of the AVP X Committee Members may be deemed to share the power to direct the disposition and vote of the shares held by ARCH X Overage. AVP X Overage LP, AVP X LLC, and the AVP X Committee Members each disclaim beneficial ownership except to the extent of any pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":454212},"source":{"system":"sec-edgar","filing":"0000950170-24-041842","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1229592/000095017024041842/ownership.xml","form_type":"4"}},{"id":1547690,"issuer":{"id":7063,"kind":"organization","name":"Boundless Bio, Inc."},"owners":[{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":1,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":2,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32074,"kind":"person","name":"NELSEN ROBERT","position":3,"cik":"0001219042","reported_name":"NELSEN ROBERT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32071,"kind":"person","name":"GILLIS STEVEN","position":4,"cik":"0001229592","reported_name":"GILLIS STEVEN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2024-04-04T20:30:41.000Z","date":"2024-04-02","kind":"exercise","planned":false,"acquired":false,"shares":586080,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents shares held directly by ARCH Venture Fund IX Overage, L.P. (ARCH IX Overage).  ARCH Venture Partners IX Overage, L.P. (AVP IX Overage LP) is the sole general partner of ARCH IX Overage."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"ARCH Venture Partners IX, LLC (AVP IX LLC) is the sole general partner of each of AVP IX LP and AVP IX Overage LP. Keith Crandell, Robert Nelsen and Clinton Bybee are managing directors of AVP IX LLC (the AVP IX MDs). AVP IX LP and AVP IX Overage LP may be deemed to beneficially own the shares held by ARCH IX and ARCH IX Overage, respectively, AVP IX LLC may be deemed to beneficially own the shares held by ARCH IX and ARCH IX Overage, and each of the AVP IX MDs may be deemed to share the power to direct the disposition and vote of the shares held by ARCH IX and ARCH IX Overage. AVP IX LP, AVP IX Overage LP, AVP IX LLC, and the AVP IX MDs each disclaim beneficial ownership except to to the extent of any pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":586080},"source":{"system":"sec-edgar","filing":"0000950170-24-041842","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1229592/000095017024041842/ownership.xml","form_type":"4"}},{"id":1547689,"issuer":{"id":7063,"kind":"organization","name":"Boundless Bio, Inc."},"owners":[{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":1,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":2,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32074,"kind":"person","name":"NELSEN ROBERT","position":3,"cik":"0001219042","reported_name":"NELSEN ROBERT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32071,"kind":"person","name":"GILLIS STEVEN","position":4,"cik":"0001229592","reported_name":"GILLIS STEVEN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2024-04-04T20:30:41.000Z","date":"2024-04-02","kind":"exercise","planned":false,"acquired":false,"shares":424908,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents shares held directly by ARCH Venture Fund IX, L.P. (ARCH IX).  ARCH Venture Partners IX, L.P. (AVP IX LP) is the sole general partner of ARCH IX."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"ARCH Venture Partners IX, LLC (AVP IX LLC) is the sole general partner of each of AVP IX LP and AVP IX Overage LP. Keith Crandell, Robert Nelsen and Clinton Bybee are managing directors of AVP IX LLC (the AVP IX MDs). AVP IX LP and AVP IX Overage LP may be deemed to beneficially own the shares held by ARCH IX and ARCH IX Overage, respectively, AVP IX LLC may be deemed to beneficially own the shares held by ARCH IX and ARCH IX Overage, and each of the AVP IX MDs may be deemed to share the power to direct the disposition and vote of the shares held by ARCH IX and ARCH IX Overage. AVP IX LP, AVP IX Overage LP, AVP IX LLC, and the AVP IX MDs each disclaim beneficial ownership except to to the extent of any pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":424908},"source":{"system":"sec-edgar","filing":"0000950170-24-041842","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1229592/000095017024041842/ownership.xml","form_type":"4"}},{"id":1547688,"issuer":{"id":7063,"kind":"organization","name":"Boundless Bio, Inc."},"owners":[{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":1,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":2,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32074,"kind":"person","name":"NELSEN ROBERT","position":3,"cik":"0001219042","reported_name":"NELSEN ROBERT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32071,"kind":"person","name":"GILLIS STEVEN","position":4,"cik":"0001229592","reported_name":"GILLIS STEVEN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-04-04T20:30:41.000Z","date":"2024-04-02","kind":"purchase","planned":false,"acquired":true,"shares":133333,"price":16,"value":2133328.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Represents shares held directly by ARCH Venture Fund X Overage, L.P. (ARCH X Overage).  ARCH Venture Partners X Overage, L.P. (AVP X Overage LP) is the sole general partner of ARCH X Overage."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"ARCH Venture Partners X, LLC (AVP X LLC) is the sole general partner of AVP X Overage LP. Keith Crandell, Robert Nelsen and Steven Gillis are members of the investment committee of AVP X LLC (the AVP X Committee Members). AVP X Overage LP may be deemed to beneficially own the shares held by ARCH X Overage, AVP X LLC may be deemed to beneficially own the shares held by ARCH X Overage, and each of the AVP X Committee Members may be deemed to share the power to direct the disposition and vote of the shares held by ARCH X Overage. AVP X Overage LP, AVP X LLC, and the AVP X Committee Members each disclaim beneficial ownership except to the extent of any pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"Reflects shares purchased by ARCH X Overage in the Issuer's initial public offering."}],"balance_after":1181766,"source":{"system":"sec-edgar","filing":"0000950170-24-041842","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1229592/000095017024041842/ownership.xml","form_type":"4"}},{"id":1547687,"issuer":{"id":7063,"kind":"organization","name":"Boundless Bio, Inc."},"owners":[{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":1,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":2,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32074,"kind":"person","name":"NELSEN ROBERT","position":3,"cik":"0001219042","reported_name":"NELSEN ROBERT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32071,"kind":"person","name":"GILLIS STEVEN","position":4,"cik":"0001229592","reported_name":"GILLIS STEVEN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-04-04T20:30:41.000Z","date":"2024-04-02","kind":"purchase","planned":false,"acquired":true,"shares":66667,"price":16,"value":1066672.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents shares held directly by ARCH Venture Fund IX, L.P. (ARCH IX).  ARCH Venture Partners IX, L.P. (AVP IX LP) is the sole general partner of ARCH IX."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"ARCH Venture Partners IX, LLC (AVP IX LLC) is the sole general partner of each of AVP IX LP and AVP IX Overage LP. Keith Crandell, Robert Nelsen and Clinton Bybee are managing directors of AVP IX LLC (the AVP IX MDs). AVP IX LP and AVP IX Overage LP may be deemed to beneficially own the shares held by ARCH IX and ARCH IX Overage, respectively, AVP IX LLC may be deemed to beneficially own the shares held by ARCH IX and ARCH IX Overage, and each of the AVP IX MDs may be deemed to share the power to direct the disposition and vote of the shares held by ARCH IX and ARCH IX Overage. AVP IX LP, AVP IX Overage LP, AVP IX LLC, and the AVP IX MDs each disclaim beneficial ownership except to to the extent of any pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Reflects shares purchased by ARCH IX in the Issuer's initial public offering."}],"balance_after":683759,"source":{"system":"sec-edgar","filing":"0000950170-24-041842","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1229592/000095017024041842/ownership.xml","form_type":"4"}},{"id":1547686,"issuer":{"id":7063,"kind":"organization","name":"Boundless Bio, Inc."},"owners":[{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":1,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":2,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32074,"kind":"person","name":"NELSEN ROBERT","position":3,"cik":"0001219042","reported_name":"NELSEN ROBERT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32071,"kind":"person","name":"GILLIS STEVEN","position":4,"cik":"0001229592","reported_name":"GILLIS STEVEN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-04-04T20:30:41.000Z","date":"2024-04-02","kind":"exercise","planned":false,"acquired":true,"shares":1048433,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Represents shares held directly by ARCH Venture Fund X Overage, L.P. (ARCH X Overage).  ARCH Venture Partners X Overage, L.P. (AVP X Overage LP) is the sole general partner of ARCH X Overage."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"ARCH Venture Partners X, LLC (AVP X LLC) is the sole general partner of AVP X Overage LP. Keith Crandell, Robert Nelsen and Steven Gillis are members of the investment committee of AVP X LLC (the AVP X Committee Members). AVP X Overage LP may be deemed to beneficially own the shares held by ARCH X Overage, AVP X LLC may be deemed to beneficially own the shares held by ARCH X Overage, and each of the AVP X Committee Members may be deemed to share the power to direct the disposition and vote of the shares held by ARCH X Overage. AVP X Overage LP, AVP X LLC, and the AVP X Committee Members each disclaim beneficial ownership except to the extent of any pecuniary interest therein, if any."}],"balance_after":1048433,"source":{"system":"sec-edgar","filing":"0000950170-24-041842","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1229592/000095017024041842/ownership.xml","form_type":"4"}},{"id":1547685,"issuer":{"id":7063,"kind":"organization","name":"Boundless Bio, Inc."},"owners":[{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":1,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":2,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32074,"kind":"person","name":"NELSEN ROBERT","position":3,"cik":"0001219042","reported_name":"NELSEN ROBERT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32071,"kind":"person","name":"GILLIS STEVEN","position":4,"cik":"0001229592","reported_name":"GILLIS STEVEN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-04-04T20:30:41.000Z","date":"2024-04-02","kind":"exercise","planned":false,"acquired":true,"shares":787545,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents shares held directly by ARCH Venture Fund IX Overage, L.P. (ARCH IX Overage).  ARCH Venture Partners IX Overage, L.P. (AVP IX Overage LP) is the sole general partner of ARCH IX Overage."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"ARCH Venture Partners IX, LLC (AVP IX LLC) is the sole general partner of each of AVP IX LP and AVP IX Overage LP. Keith Crandell, Robert Nelsen and Clinton Bybee are managing directors of AVP IX LLC (the AVP IX MDs). AVP IX LP and AVP IX Overage LP may be deemed to beneficially own the shares held by ARCH IX and ARCH IX Overage, respectively, AVP IX LLC may be deemed to beneficially own the shares held by ARCH IX and ARCH IX Overage, and each of the AVP IX MDs may be deemed to share the power to direct the disposition and vote of the shares held by ARCH IX and ARCH IX Overage. AVP IX LP, AVP IX Overage LP, AVP IX LLC, and the AVP IX MDs each disclaim beneficial ownership except to to the extent of any pecuniary interest therein, if any."}],"balance_after":828570,"source":{"system":"sec-edgar","filing":"0000950170-24-041842","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1229592/000095017024041842/ownership.xml","form_type":"4"}},{"id":1547684,"issuer":{"id":7063,"kind":"organization","name":"Boundless Bio, Inc."},"owners":[{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":1,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":2,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32074,"kind":"person","name":"NELSEN ROBERT","position":3,"cik":"0001219042","reported_name":"NELSEN ROBERT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32071,"kind":"person","name":"GILLIS STEVEN","position":4,"cik":"0001229592","reported_name":"GILLIS STEVEN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-04-04T20:30:41.000Z","date":"2024-04-02","kind":"exercise","planned":false,"acquired":true,"shares":589743,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents shares held directly by ARCH Venture Fund IX, L.P. (ARCH IX).  ARCH Venture Partners IX, L.P. (AVP IX LP) is the sole general partner of ARCH IX."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"ARCH Venture Partners IX, LLC (AVP IX LLC) is the sole general partner of each of AVP IX LP and AVP IX Overage LP. Keith Crandell, Robert Nelsen and Clinton Bybee are managing directors of AVP IX LLC (the AVP IX MDs). AVP IX LP and AVP IX Overage LP may be deemed to beneficially own the shares held by ARCH IX and ARCH IX Overage, respectively, AVP IX LLC may be deemed to beneficially own the shares held by ARCH IX and ARCH IX Overage, and each of the AVP IX MDs may be deemed to share the power to direct the disposition and vote of the shares held by ARCH IX and ARCH IX Overage. AVP IX LP, AVP IX Overage LP, AVP IX LLC, and the AVP IX MDs each disclaim beneficial ownership except to to the extent of any pecuniary interest therein, if any."}],"balance_after":617092,"source":{"system":"sec-edgar","filing":"0000950170-24-041842","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1229592/000095017024041842/ownership.xml","form_type":"4"}},{"id":1648965,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":1,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":2,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32075,"kind":"person","name":"Burow Kristina","position":3,"cik":"0001569248","reported_name":"Burow Kristina","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32071,"kind":"person","name":"GILLIS STEVEN","position":4,"cik":"0001229592","reported_name":"GILLIS STEVEN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-02-12T22:43:56.000Z","date":"2024-02-08","kind":"purchase","planned":false,"acquired":true,"shares":727272,"price":5.5,"value":3999996.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Represents shares held directly by ARCH Venture Fund X Overage, L.P. (ARCH X Overage).  ARCH Venture Partners X Overage, L.P. (AVP X Overage LP) is the sole general partner of ARCH X Overage."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"ARCH Venture Partners X, LLC (AVP X LLC) is the sole general partner of each of AVP X LP and AVP X Overage LP. Keith Crandell, Kristina Burow and Steven Gillis are members of the investment committee of AVP X LLC (the AVP X Committee Members). AVP X LP and AVP X Overage LP may be deemed to beneficially own the shares held by ARCH X and ARCH X Overage, respectively, AVP X LLC may be deemed to beneficially own the shares held by ARCH X and ARCH X Overage, and each of the AVP X Committee Members may be deemed to share the power to direct the disposition and vote of the shares held by ARCH X and ARCH X Overage. AVP X LP, AVP X Overage LP, AVP X LLC, and the AVP X Committee Members each disclaim beneficial ownership except to the extent of any pecuniary interest therein."}],"balance_after":12446022,"source":{"system":"sec-edgar","filing":"0001062993-24-002841","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1229592/000106299324002841/form4.xml","form_type":"4"}},{"id":1648964,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":1,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":2,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32075,"kind":"person","name":"Burow Kristina","position":3,"cik":"0001569248","reported_name":"Burow Kristina","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32071,"kind":"person","name":"GILLIS STEVEN","position":4,"cik":"0001229592","reported_name":"GILLIS STEVEN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-02-12T22:43:56.000Z","date":"2024-02-08","kind":"purchase","planned":false,"acquired":true,"shares":727272,"price":5.5,"value":3999996.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Represents shares held directly by ARCH Venture Fund X, L.P. (ARCH X).  ARCH Venture Partners X, L.P. (AVP X LP) is the sole general partner of ARCH X."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"ARCH Venture Partners X, LLC (AVP X LLC) is the sole general partner of each of AVP X LP and AVP X Overage LP. Keith Crandell, Kristina Burow and Steven Gillis are members of the investment committee of AVP X LLC (the AVP X Committee Members). AVP X LP and AVP X Overage LP may be deemed to beneficially own the shares held by ARCH X and ARCH X Overage, respectively, AVP X LLC may be deemed to beneficially own the shares held by ARCH X and ARCH X Overage, and each of the AVP X Committee Members may be deemed to share the power to direct the disposition and vote of the shares held by ARCH X and ARCH X Overage. AVP X LP, AVP X Overage LP, AVP X LLC, and the AVP X Committee Members each disclaim beneficial ownership except to the extent of any pecuniary interest therein."}],"balance_after":12446022,"source":{"system":"sec-edgar","filing":"0001062993-24-002841","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1229592/000106299324002841/form4.xml","form_type":"4"}},{"id":1648963,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":1,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":2,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32075,"kind":"person","name":"Burow Kristina","position":3,"cik":"0001569248","reported_name":"Burow Kristina","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32071,"kind":"person","name":"GILLIS STEVEN","position":4,"cik":"0001229592","reported_name":"GILLIS STEVEN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-02-12T22:43:56.000Z","date":"2024-02-08","kind":"purchase","planned":false,"acquired":true,"shares":363637,"price":5.5,"value":2000003.5,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents shares held directly by ARCH Venture Fund IX, L.P. (ARCH IX).  ARCH Venture Partners IX, L.P. (AVP IX LP) is the sole general partner of ARCH IX."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"ARCH Venture Partners IX, LLC (AVP IX LLC) is the sole general partner of each of AVP IX LP and AVP IX Overage LP. Keith Crandell and Clinton Bybee are managing directors of AVP IX LLC (the AVP IX MDs). AVP IX LP and AVP IX Overage LP may be deemed to beneficially own the shares held by ARCH IX and ARCH IX Overage, respectively, AVP IX LLC may be deemed to beneficially own the shares held by ARCH IX and ARCH IX Overage, and each of the AVP IX MDs may be deemed to share the power to direct the disposition and vote of the shares held by ARCH IX and ARCH IX Overage. AVP IX LP, AVP IX Overage LP, AVP IX LLC, and the AVP IX MDs each disclaim beneficial ownership except to to the extent of any pecuniary interest therein."}],"balance_after":10667387,"source":{"system":"sec-edgar","filing":"0001062993-24-002841","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1229592/000106299324002841/form4.xml","form_type":"4"}},{"id":1714601,"issuer":{"id":6115,"kind":"organization","name":"Neumora Therapeutics, Inc."},"owners":[{"id":50020,"kind":"organization","name":"ARCH Venture Partners XII, LLC","position":1,"cik":"0001979548","reported_name":"ARCH Venture Partners XII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50021,"kind":"organization","name":"ARCH Venture Partners XII, L.P.","position":2,"cik":"0001979765","reported_name":"ARCH Venture Partners XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50022,"kind":"organization","name":"ARCH Venture Fund XII, L.P.","position":3,"cik":"0001906837","reported_name":"ARCH Venture Fund XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":4,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32071,"kind":"person","name":"GILLIS STEVEN","position":5,"cik":"0001229592","reported_name":"GILLIS STEVEN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32074,"kind":"person","name":"NELSEN ROBERT","position":6,"cik":"0001219042","reported_name":"NELSEN ROBERT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-12-13T00:53:13.000Z","date":"2023-12-08","kind":"other","planned":false,"acquired":true,"shares":1176593,"ownership":{"direct":false,"nature":"By ARCH Venture Fund VIII Overage, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares received as contingent consideration as a result of the completion of a contractual milestone being achieved by the Issuer.  Issuer acquired Blackthorn Therapeutics, Inc. and agreed to pay in cash or in stock, at Issuer's discretion, to  former stockholders of BlackThorn Therapeutics upon satisfaction of certain contractual milestones.  Shares were received without any action by Reporting Persons.  No additional consideration was paid for the shares."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents shares held directly by ARCH Venture Fund VII, L.P. (ARCH VII). ARCH Venture Partners VII, L.P. (AVP VII LP) is the sole general partner of ARCH VII, and ARCH Venture Partners VII, LLC (AVP VII LLC) is the sole general partner of AVP VII LP. Clinton Bybee, Keith Crandell and Robert Nelsen are the managing directors of AVP VII LLC (AVP VII LLC Managing Directors). AVP VII LP and AVP VII LLC may be deemed to beneficially own the shares held by ARCH VII, and each of the AVP VII LLC Managing Directors may be deemed to share the power to direct the disposition and vote of the shares held by ARCH VII. Each of AVP VII LP, AVP VII LLC and the AVP VII LLC Managing Directors disclaims beneficial ownership except to the extent of their pecuniary interest therein, if any."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents shares held directly by ARCH Venture Fund VIII Overage, L.P. (ARCH VIII Overage). ARCH Venture Partners VIII, LLC (AVP VIII LLC) is the general partner of ARCH VIII Overage. Clinton Bybee, Keith Crandell and Robert Nelsen are the managing directors of AVP VIII LLC (the AVP VIII LLC Managing Directors). AVP VIII LLC may be deemed to beneficially own the shares held by ARCH VIII Overage, and each of the AVP VIII LLC Managing Directors may be deemed to share the power to direct the disposition and vote of the shares held by ARCH VIII Overage. Each of AVP VIII LLC and the AVP VIII LLC Managing Directors disclaims beneficial ownership except to the extent of their pecuniary interest therein, if any."}],"balance_after":2321566,"source":{"system":"sec-edgar","filing":"0001062993-23-022481","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1885522/000106299323022481/form4.xml","form_type":"4"}},{"id":1714600,"issuer":{"id":6115,"kind":"organization","name":"Neumora Therapeutics, Inc."},"owners":[{"id":50020,"kind":"organization","name":"ARCH Venture Partners XII, LLC","position":1,"cik":"0001979548","reported_name":"ARCH Venture Partners XII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50021,"kind":"organization","name":"ARCH Venture Partners XII, L.P.","position":2,"cik":"0001979765","reported_name":"ARCH Venture Partners XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50022,"kind":"organization","name":"ARCH Venture Fund XII, L.P.","position":3,"cik":"0001906837","reported_name":"ARCH Venture Fund XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":4,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32071,"kind":"person","name":"GILLIS STEVEN","position":5,"cik":"0001229592","reported_name":"GILLIS STEVEN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32074,"kind":"person","name":"NELSEN ROBERT","position":6,"cik":"0001219042","reported_name":"NELSEN ROBERT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-12-13T00:53:13.000Z","date":"2023-12-08","kind":"other","planned":false,"acquired":true,"shares":703061,"ownership":{"direct":false,"nature":"By ARCH Venture Fund VII, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares received as contingent consideration as a result of the completion of a contractual milestone being achieved by the Issuer.  Issuer acquired Blackthorn Therapeutics, Inc. and agreed to pay in cash or in stock, at Issuer's discretion, to  former stockholders of BlackThorn Therapeutics upon satisfaction of certain contractual milestones.  Shares were received without any action by Reporting Persons.  No additional consideration was paid for the shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares received as contingent consideration as a result of the completion of a contractual milestone being achieved by the Issuer.  Issuer acquired Blackthorn Therapeutics, Inc. and agreed to pay in cash or in stock, at Issuer's discretion, to  former stockholders of BlackThorn Therapeutics upon satisfaction of certain contractual milestones.  Shares were received without any action by Reporting Persons.  No additional consideration was paid for the shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents shares held directly by ARCH Venture Fund VII, L.P. (ARCH VII). ARCH Venture Partners VII, L.P. (AVP VII LP) is the sole general partner of ARCH VII, and ARCH Venture Partners VII, LLC (AVP VII LLC) is the sole general partner of AVP VII LP. Clinton Bybee, Keith Crandell and Robert Nelsen are the managing directors of AVP VII LLC (AVP VII LLC Managing Directors). AVP VII LP and AVP VII LLC may be deemed to beneficially own the shares held by ARCH VII, and each of the AVP VII LLC Managing Directors may be deemed to share the power to direct the disposition and vote of the shares held by ARCH VII. Each of AVP VII LP, AVP VII LLC and the AVP VII LLC Managing Directors disclaims beneficial ownership except to the extent of their pecuniary interest therein, if any."}],"balance_after":1387228,"source":{"system":"sec-edgar","filing":"0001062993-23-022481","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1885522/000106299323022481/form4.xml","form_type":"4"}},{"id":1776339,"issuer":{"id":6115,"kind":"organization","name":"Neumora Therapeutics, Inc."},"owners":[{"id":32128,"kind":"organization","name":"ARCH Venture Partners X, LLC","position":1,"cik":"0001769012","reported_name":"ARCH Venture Partners X, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50020,"kind":"organization","name":"ARCH Venture Partners XII, LLC","position":2,"cik":"0001979548","reported_name":"ARCH Venture Partners XII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50021,"kind":"organization","name":"ARCH Venture Partners XII, L.P.","position":3,"cik":"0001979765","reported_name":"ARCH Venture Partners XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50022,"kind":"organization","name":"ARCH Venture Fund XII, L.P.","position":4,"cik":"0001906837","reported_name":"ARCH Venture Fund XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":5,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32071,"kind":"person","name":"GILLIS STEVEN","position":6,"cik":"0001229592","reported_name":"GILLIS STEVEN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32074,"kind":"person","name":"NELSEN ROBERT","position":7,"cik":"0001219042","reported_name":"NELSEN ROBERT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":8,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2023-09-20T10:16:19.000Z","date":"2023-09-19","kind":"exercise","planned":false,"acquired":false,"shares":2124143,"ownership":{"direct":false,"nature":"By ARCH Venture Fund XII, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The shares of Series A-1 Preferred Stock, Series A-2 Preferred Stock and Series B Preferred Stock of the Issuer automatically converted on a 1-for-1 basis into Common Stock of the Issuer immediately prior to the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of Series A-1 Preferred Stock, Series A-2 Preferred Stock and Series B Preferred Stock of the Issuer automatically converted on a 1-for-1 basis into Common Stock of the Issuer immediately prior to the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of Series A-1 Preferred Stock, Series A-2 Preferred Stock and Series B Preferred Stock of the Issuer automatically converted on a 1-for-1 basis into Common Stock of the Issuer immediately prior to the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The shares of Series A-1 Preferred Stock, Series A-2 Preferred Stock and Series B Preferred Stock of the Issuer automatically converted on a 1-for-1 basis into Common Stock of the Issuer immediately prior to the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Represents shares held directly by ARCH Venture Fund XII, L.P. (ARCH XII). ARCH Venture Partners XII, L.P. (AVP XII LP) is the general partner of ARCH XII. ARCH Venture Partners XII, LLC (AVP XII LLC) is the general partner of AVP XII LP.  Keith Crandell, Kristina Burow, Steven Gillis and Robert Nelsen comprise the investment committee of AVP XII LLC (the AVP XII LLC Committee Members). Each of AVP XII LP and AVP XII LLC may be deemed to beneficially own the shares held by ARCH XII, and each of the AVP XII LLC Committee Members may be deemed to share the power to direct the disposition and vote of the shares held by ARCH XII. Each of AVP XII LP, AVP XII LLC and the AVP XII LLC Committee Members disclaims beneficial ownership except to the extent of their pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2124143},"source":{"system":"sec-edgar","filing":"0000899243-23-019274","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1885522/000089924323019274/doc4.xml","form_type":"4"}},{"id":1776338,"issuer":{"id":6115,"kind":"organization","name":"Neumora Therapeutics, Inc."},"owners":[{"id":32128,"kind":"organization","name":"ARCH Venture Partners X, LLC","position":1,"cik":"0001769012","reported_name":"ARCH Venture Partners X, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50020,"kind":"organization","name":"ARCH Venture Partners XII, LLC","position":2,"cik":"0001979548","reported_name":"ARCH Venture Partners XII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50021,"kind":"organization","name":"ARCH Venture Partners XII, L.P.","position":3,"cik":"0001979765","reported_name":"ARCH Venture Partners XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50022,"kind":"organization","name":"ARCH Venture Fund XII, L.P.","position":4,"cik":"0001906837","reported_name":"ARCH Venture Fund XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":5,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32071,"kind":"person","name":"GILLIS STEVEN","position":6,"cik":"0001229592","reported_name":"GILLIS STEVEN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32074,"kind":"person","name":"NELSEN ROBERT","position":7,"cik":"0001219042","reported_name":"NELSEN ROBERT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":8,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-2 Preferred Stock","published_at":"2023-09-20T10:16:19.000Z","date":"2023-09-19","kind":"exercise","planned":false,"acquired":false,"shares":6576400,"ownership":{"direct":false,"nature":"By ARCH Venture Fund X Overage, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The shares of Series A-1 Preferred Stock, Series A-2 Preferred Stock and Series B Preferred Stock of the Issuer automatically converted on a 1-for-1 basis into Common Stock of the Issuer immediately prior to the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of Series A-1 Preferred Stock, Series A-2 Preferred Stock and Series B Preferred Stock of the Issuer automatically converted on a 1-for-1 basis into Common Stock of the Issuer immediately prior to the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of Series A-1 Preferred Stock, Series A-2 Preferred Stock and Series B Preferred Stock of the Issuer automatically converted on a 1-for-1 basis into Common Stock of the Issuer immediately prior to the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The shares of Series A-1 Preferred Stock, Series A-2 Preferred Stock and Series B Preferred Stock of the Issuer automatically converted on a 1-for-1 basis into Common Stock of the Issuer immediately prior to the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Represents shares held directly by ARCH Venture Fund X Overage, L.P. (ARCH X Overage). ARCH Venture Partners X Overage, L.P. (AVP X Overage LP) is the sole general partner of ARCH X Overage."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"ARCH Venture Partners X, LLC (AVP X LLC) is the sole general partner of each of AVP X LP and AVP X Overage LP.  Keith Crandell, Kristina Burow, Steven Gillis and Robert Nelsen comprise the investment committee of AVP X LLC (the AVP X Committee Members). AVP X LLC may be deemed to beneficially own the shares held by ARCH X and ARCH X Overage, and each of the AVP X Committee Members may be deemed to share the power to direct the disposition and vote of the shares held by ARCH X and ARCH X Overage. Each of AVP X LP, AVP X Overage LP, AVP X LLC and the AVP X Committee Members disclaims beneficial ownership of such shares except to the extent of their pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6576400},"source":{"system":"sec-edgar","filing":"0000899243-23-019274","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1885522/000089924323019274/doc4.xml","form_type":"4"}},{"id":1776337,"issuer":{"id":6115,"kind":"organization","name":"Neumora Therapeutics, Inc."},"owners":[{"id":32128,"kind":"organization","name":"ARCH Venture Partners X, LLC","position":1,"cik":"0001769012","reported_name":"ARCH Venture Partners X, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50020,"kind":"organization","name":"ARCH Venture Partners XII, LLC","position":2,"cik":"0001979548","reported_name":"ARCH Venture Partners XII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50021,"kind":"organization","name":"ARCH Venture Partners XII, L.P.","position":3,"cik":"0001979765","reported_name":"ARCH Venture Partners XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50022,"kind":"organization","name":"ARCH Venture Fund XII, L.P.","position":4,"cik":"0001906837","reported_name":"ARCH Venture Fund XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":5,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32071,"kind":"person","name":"GILLIS STEVEN","position":6,"cik":"0001229592","reported_name":"GILLIS STEVEN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32074,"kind":"person","name":"NELSEN ROBERT","position":7,"cik":"0001219042","reported_name":"NELSEN ROBERT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":8,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-2 Preferred Stock","published_at":"2023-09-20T10:16:19.000Z","date":"2023-09-19","kind":"exercise","planned":false,"acquired":false,"shares":6895021,"ownership":{"direct":false,"nature":"By ARCH Venture Fund X, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The shares of Series A-1 Preferred Stock, Series A-2 Preferred Stock and Series B Preferred Stock of the Issuer automatically converted on a 1-for-1 basis into Common Stock of the Issuer immediately prior to the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of Series A-1 Preferred Stock, Series A-2 Preferred Stock and Series B Preferred Stock of the Issuer automatically converted on a 1-for-1 basis into Common Stock of the Issuer immediately prior to the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of Series A-1 Preferred Stock, Series A-2 Preferred Stock and Series B Preferred Stock of the Issuer automatically converted on a 1-for-1 basis into Common Stock of the Issuer immediately prior to the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The shares of Series A-1 Preferred Stock, Series A-2 Preferred Stock and Series B Preferred Stock of the Issuer automatically converted on a 1-for-1 basis into Common Stock of the Issuer immediately prior to the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Represents shares held directly by ARCH Venture Fund X, L.P. (ARCH X). ARCH Venture Partners X, L.P. (AVP X LP) is the sole general partner of ARCH X."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"ARCH Venture Partners X, LLC (AVP X LLC) is the sole general partner of each of AVP X LP and AVP X Overage LP.  Keith Crandell, Kristina Burow, Steven Gillis and Robert Nelsen comprise the investment committee of AVP X LLC (the AVP X Committee Members). AVP X LLC may be deemed to beneficially own the shares held by ARCH X and ARCH X Overage, and each of the AVP X Committee Members may be deemed to share the power to direct the disposition and vote of the shares held by ARCH X and ARCH X Overage. Each of AVP X LP, AVP X Overage LP, AVP X LLC and the AVP X Committee Members disclaims beneficial ownership of such shares except to the extent of their pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6895021},"source":{"system":"sec-edgar","filing":"0000899243-23-019274","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1885522/000089924323019274/doc4.xml","form_type":"4"}},{"id":1776336,"issuer":{"id":6115,"kind":"organization","name":"Neumora Therapeutics, Inc."},"owners":[{"id":32128,"kind":"organization","name":"ARCH Venture Partners X, LLC","position":1,"cik":"0001769012","reported_name":"ARCH Venture Partners X, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50020,"kind":"organization","name":"ARCH Venture Partners XII, LLC","position":2,"cik":"0001979548","reported_name":"ARCH Venture Partners XII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50021,"kind":"organization","name":"ARCH Venture Partners XII, L.P.","position":3,"cik":"0001979765","reported_name":"ARCH Venture Partners XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50022,"kind":"organization","name":"ARCH Venture Fund XII, L.P.","position":4,"cik":"0001906837","reported_name":"ARCH Venture Fund XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":5,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32071,"kind":"person","name":"GILLIS STEVEN","position":6,"cik":"0001229592","reported_name":"GILLIS STEVEN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32074,"kind":"person","name":"NELSEN ROBERT","position":7,"cik":"0001219042","reported_name":"NELSEN ROBERT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":8,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-1 Preferred Stock","published_at":"2023-09-20T10:16:19.000Z","date":"2023-09-19","kind":"exercise","planned":false,"acquired":false,"shares":1144973,"ownership":{"direct":false,"nature":"By ARCH Venture Fund VIII Overage, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The shares of Series A-1 Preferred Stock, Series A-2 Preferred Stock and Series B Preferred Stock of the Issuer automatically converted on a 1-for-1 basis into Common Stock of the Issuer immediately prior to the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of Series A-1 Preferred Stock, Series A-2 Preferred Stock and Series B Preferred Stock of the Issuer automatically converted on a 1-for-1 basis into Common Stock of the Issuer immediately prior to the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of Series A-1 Preferred Stock, Series A-2 Preferred Stock and Series B Preferred Stock of the Issuer automatically converted on a 1-for-1 basis into Common Stock of the Issuer immediately prior to the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The shares of Series A-1 Preferred Stock, Series A-2 Preferred Stock and Series B Preferred Stock of the Issuer automatically converted on a 1-for-1 basis into Common Stock of the Issuer immediately prior to the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents shares held directly by ARCH Venture Fund VIII Overage, L.P. (ARCH VIII Overage). ARCH Venture Partners VIII, LLC (AVP VIII LLC) is the general partner of ARCH VIII Overage. Clinton Bybee, Keith Crandell and Robert Nelsen are the managing directors of AVP VIII LLC (the AVP VIII LLC Managing Directors). AVP VIII LLC may be deemed to beneficially own the shares held by ARCH VIII Overage, and each of the AVP VIII LLC Managing Directors may be deemed to share the power to direct the disposition and vote of the shares held by ARCH VIII Overage. Each of AVP VIII LLC and the AVP VIII LLC Managing Directors disclaims beneficial ownership except to the extent of their pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1144973},"source":{"system":"sec-edgar","filing":"0000899243-23-019274","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1885522/000089924323019274/doc4.xml","form_type":"4"}},{"id":1776335,"issuer":{"id":6115,"kind":"organization","name":"Neumora Therapeutics, Inc."},"owners":[{"id":32128,"kind":"organization","name":"ARCH Venture Partners X, LLC","position":1,"cik":"0001769012","reported_name":"ARCH Venture Partners X, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50020,"kind":"organization","name":"ARCH Venture Partners XII, LLC","position":2,"cik":"0001979548","reported_name":"ARCH Venture Partners XII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50021,"kind":"organization","name":"ARCH Venture Partners XII, L.P.","position":3,"cik":"0001979765","reported_name":"ARCH Venture Partners XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50022,"kind":"organization","name":"ARCH Venture Fund XII, L.P.","position":4,"cik":"0001906837","reported_name":"ARCH Venture Fund XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":5,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32071,"kind":"person","name":"GILLIS STEVEN","position":6,"cik":"0001229592","reported_name":"GILLIS STEVEN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32074,"kind":"person","name":"NELSEN ROBERT","position":7,"cik":"0001219042","reported_name":"NELSEN ROBERT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":8,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A-1 Preferred Stock","published_at":"2023-09-20T10:16:19.000Z","date":"2023-09-19","kind":"exercise","planned":false,"acquired":false,"shares":684167,"ownership":{"direct":false,"nature":"By ARCH Venture Fund VII, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The shares of Series A-1 Preferred Stock, Series A-2 Preferred Stock and Series B Preferred Stock of the Issuer automatically converted on a 1-for-1 basis into Common Stock of the Issuer immediately prior to the closing of the Issuer's initial public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of Series A-1 Preferred Stock, Series A-2 Preferred Stock and Series B Preferred Stock of the Issuer automatically converted on a 1-for-1 basis into Common Stock of the Issuer immediately prior to the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of Series A-1 Preferred Stock, Series A-2 Preferred Stock and Series B Preferred Stock of the Issuer automatically converted on a 1-for-1 basis into Common Stock of the Issuer immediately prior to the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The shares of Series A-1 Preferred Stock, Series A-2 Preferred Stock and Series B Preferred Stock of the Issuer automatically converted on a 1-for-1 basis into Common Stock of the Issuer immediately prior to the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents shares held directly by ARCH Venture Fund VII, L.P. (ARCH VII). ARCH Venture Partners VII, L.P. (AVP VII LP) is the sole general partner of ARCH VII, and ARCH Venture Partners VII, LLC (AVP VII LLC) is the sole general partner of AVP VII LP. Clinton Bybee, Keith Crandell and Robert Nelsen are the managing directors of AVP VII LLC (AVP VII LLC Managing Directors). AVP VII LP and AVP VII LLC may be deemed to beneficially own the shares held by ARCH VII, and each of the AVP VII LLC Managing Directors may be deemed to share the power to direct the disposition and vote of the shares held by ARCH VII. Each of AVP VII LP, AVP VII LLC and the AVP VII LLC Managing Directors disclaims beneficial ownership except to the extent of their pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":684167},"source":{"system":"sec-edgar","filing":"0000899243-23-019274","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1885522/000089924323019274/doc4.xml","form_type":"4"}},{"id":1776334,"issuer":{"id":6115,"kind":"organization","name":"Neumora Therapeutics, Inc."},"owners":[{"id":32128,"kind":"organization","name":"ARCH Venture Partners X, LLC","position":1,"cik":"0001769012","reported_name":"ARCH Venture Partners X, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50020,"kind":"organization","name":"ARCH Venture Partners XII, LLC","position":2,"cik":"0001979548","reported_name":"ARCH Venture Partners XII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50021,"kind":"organization","name":"ARCH Venture Partners XII, L.P.","position":3,"cik":"0001979765","reported_name":"ARCH Venture Partners XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50022,"kind":"organization","name":"ARCH Venture Fund XII, L.P.","position":4,"cik":"0001906837","reported_name":"ARCH Venture Fund XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":5,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32071,"kind":"person","name":"GILLIS STEVEN","position":6,"cik":"0001229592","reported_name":"GILLIS STEVEN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32074,"kind":"person","name":"NELSEN ROBERT","position":7,"cik":"0001219042","reported_name":"NELSEN ROBERT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":8,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-09-20T10:16:19.000Z","date":"2023-09-19","kind":"purchase","planned":false,"acquired":true,"shares":1500000,"price":17,"value":25500000.0,"ownership":{"direct":false,"nature":"By ARCH Venture Fund XII, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Represents shares held directly by ARCH Venture Fund XII, L.P. (ARCH XII). ARCH Venture Partners XII, L.P. (AVP XII LP) is the general partner of ARCH XII. ARCH Venture Partners XII, LLC (AVP XII LLC) is the general partner of AVP XII LP.  Keith Crandell, Kristina Burow, Steven Gillis and Robert Nelsen comprise the investment committee of AVP XII LLC (the AVP XII LLC Committee Members). Each of AVP XII LP and AVP XII LLC may be deemed to beneficially own the shares held by ARCH XII, and each of the AVP XII LLC Committee Members may be deemed to share the power to direct the disposition and vote of the shares held by ARCH XII. Each of AVP XII LP, AVP XII LLC and the AVP XII LLC Committee Members disclaims beneficial ownership except to the extent of their pecuniary interest therein, if any."}],"balance_after":3624143,"source":{"system":"sec-edgar","filing":"0000899243-23-019274","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1885522/000089924323019274/doc4.xml","form_type":"4"}},{"id":1776333,"issuer":{"id":6115,"kind":"organization","name":"Neumora Therapeutics, Inc."},"owners":[{"id":32128,"kind":"organization","name":"ARCH Venture Partners X, LLC","position":1,"cik":"0001769012","reported_name":"ARCH Venture Partners X, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50020,"kind":"organization","name":"ARCH Venture Partners XII, LLC","position":2,"cik":"0001979548","reported_name":"ARCH Venture Partners XII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50021,"kind":"organization","name":"ARCH Venture Partners XII, L.P.","position":3,"cik":"0001979765","reported_name":"ARCH Venture Partners XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50022,"kind":"organization","name":"ARCH Venture Fund XII, L.P.","position":4,"cik":"0001906837","reported_name":"ARCH Venture Fund XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":5,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32071,"kind":"person","name":"GILLIS STEVEN","position":6,"cik":"0001229592","reported_name":"GILLIS STEVEN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32074,"kind":"person","name":"NELSEN ROBERT","position":7,"cik":"0001219042","reported_name":"NELSEN ROBERT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":8,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-09-20T10:16:19.000Z","date":"2023-09-19","kind":"exercise","planned":false,"acquired":true,"shares":2124143,"ownership":{"direct":false,"nature":"By ARCH Venture Fund XII, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of Series A-1 Preferred Stock, Series A-2 Preferred Stock and Series B Preferred Stock of the Issuer automatically converted on a 1-for-1 basis into Common Stock of the Issuer immediately prior to the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Represents shares held directly by ARCH Venture Fund XII, L.P. (ARCH XII). ARCH Venture Partners XII, L.P. (AVP XII LP) is the general partner of ARCH XII. ARCH Venture Partners XII, LLC (AVP XII LLC) is the general partner of AVP XII LP.  Keith Crandell, Kristina Burow, Steven Gillis and Robert Nelsen comprise the investment committee of AVP XII LLC (the AVP XII LLC Committee Members). Each of AVP XII LP and AVP XII LLC may be deemed to beneficially own the shares held by ARCH XII, and each of the AVP XII LLC Committee Members may be deemed to share the power to direct the disposition and vote of the shares held by ARCH XII. Each of AVP XII LP, AVP XII LLC and the AVP XII LLC Committee Members disclaims beneficial ownership except to the extent of their pecuniary interest therein, if any."}],"balance_after":2124143,"source":{"system":"sec-edgar","filing":"0000899243-23-019274","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1885522/000089924323019274/doc4.xml","form_type":"4"}},{"id":1776332,"issuer":{"id":6115,"kind":"organization","name":"Neumora Therapeutics, Inc."},"owners":[{"id":32128,"kind":"organization","name":"ARCH Venture Partners X, LLC","position":1,"cik":"0001769012","reported_name":"ARCH Venture Partners X, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50020,"kind":"organization","name":"ARCH Venture Partners XII, LLC","position":2,"cik":"0001979548","reported_name":"ARCH Venture Partners XII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50021,"kind":"organization","name":"ARCH Venture Partners XII, L.P.","position":3,"cik":"0001979765","reported_name":"ARCH Venture Partners XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50022,"kind":"organization","name":"ARCH Venture Fund XII, L.P.","position":4,"cik":"0001906837","reported_name":"ARCH Venture Fund XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":5,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32071,"kind":"person","name":"GILLIS STEVEN","position":6,"cik":"0001229592","reported_name":"GILLIS STEVEN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32074,"kind":"person","name":"NELSEN ROBERT","position":7,"cik":"0001219042","reported_name":"NELSEN ROBERT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":8,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-09-20T10:16:19.000Z","date":"2023-09-19","kind":"exercise","planned":false,"acquired":true,"shares":6576400,"ownership":{"direct":false,"nature":"By ARCH Venture Fund X Overage, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of Series A-1 Preferred Stock, Series A-2 Preferred Stock and Series B Preferred Stock of the Issuer automatically converted on a 1-for-1 basis into Common Stock of the Issuer immediately prior to the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Represents shares held directly by ARCH Venture Fund X Overage, L.P. (ARCH X Overage). ARCH Venture Partners X Overage, L.P. (AVP X Overage LP) is the sole general partner of ARCH X Overage."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"ARCH Venture Partners X, LLC (AVP X LLC) is the sole general partner of each of AVP X LP and AVP X Overage LP.  Keith Crandell, Kristina Burow, Steven Gillis and Robert Nelsen comprise the investment committee of AVP X LLC (the AVP X Committee Members). AVP X LLC may be deemed to beneficially own the shares held by ARCH X and ARCH X Overage, and each of the AVP X Committee Members may be deemed to share the power to direct the disposition and vote of the shares held by ARCH X and ARCH X Overage. Each of AVP X LP, AVP X Overage LP, AVP X LLC and the AVP X Committee Members disclaims beneficial ownership of such shares except to the extent of their pecuniary interest therein, if any."}],"balance_after":11886758,"source":{"system":"sec-edgar","filing":"0000899243-23-019274","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1885522/000089924323019274/doc4.xml","form_type":"4"}},{"id":1776331,"issuer":{"id":6115,"kind":"organization","name":"Neumora Therapeutics, Inc."},"owners":[{"id":32128,"kind":"organization","name":"ARCH Venture Partners X, LLC","position":1,"cik":"0001769012","reported_name":"ARCH Venture Partners X, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50020,"kind":"organization","name":"ARCH Venture Partners XII, LLC","position":2,"cik":"0001979548","reported_name":"ARCH Venture Partners XII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50021,"kind":"organization","name":"ARCH Venture Partners XII, L.P.","position":3,"cik":"0001979765","reported_name":"ARCH Venture Partners XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50022,"kind":"organization","name":"ARCH Venture Fund XII, L.P.","position":4,"cik":"0001906837","reported_name":"ARCH Venture Fund XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":5,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32071,"kind":"person","name":"GILLIS STEVEN","position":6,"cik":"0001229592","reported_name":"GILLIS STEVEN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32074,"kind":"person","name":"NELSEN ROBERT","position":7,"cik":"0001219042","reported_name":"NELSEN ROBERT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":8,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-09-20T10:16:19.000Z","date":"2023-09-19","kind":"exercise","planned":false,"acquired":true,"shares":6895021,"ownership":{"direct":false,"nature":"By ARCH Venture Fund X, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of Series A-1 Preferred Stock, Series A-2 Preferred Stock and Series B Preferred Stock of the Issuer automatically converted on a 1-for-1 basis into Common Stock of the Issuer immediately prior to the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Represents shares held directly by ARCH Venture Fund X, L.P. (ARCH X). ARCH Venture Partners X, L.P. (AVP X LP) is the sole general partner of ARCH X."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"ARCH Venture Partners X, LLC (AVP X LLC) is the sole general partner of each of AVP X LP and AVP X Overage LP.  Keith Crandell, Kristina Burow, Steven Gillis and Robert Nelsen comprise the investment committee of AVP X LLC (the AVP X Committee Members). AVP X LLC may be deemed to beneficially own the shares held by ARCH X and ARCH X Overage, and each of the AVP X Committee Members may be deemed to share the power to direct the disposition and vote of the shares held by ARCH X and ARCH X Overage. Each of AVP X LP, AVP X Overage LP, AVP X LLC and the AVP X Committee Members disclaims beneficial ownership of such shares except to the extent of their pecuniary interest therein, if any."}],"balance_after":12205379,"source":{"system":"sec-edgar","filing":"0000899243-23-019274","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1885522/000089924323019274/doc4.xml","form_type":"4"}},{"id":1776330,"issuer":{"id":6115,"kind":"organization","name":"Neumora Therapeutics, Inc."},"owners":[{"id":32128,"kind":"organization","name":"ARCH Venture Partners X, LLC","position":1,"cik":"0001769012","reported_name":"ARCH Venture Partners X, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50020,"kind":"organization","name":"ARCH Venture Partners XII, LLC","position":2,"cik":"0001979548","reported_name":"ARCH Venture Partners XII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50021,"kind":"organization","name":"ARCH Venture Partners XII, L.P.","position":3,"cik":"0001979765","reported_name":"ARCH Venture Partners XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50022,"kind":"organization","name":"ARCH Venture Fund XII, L.P.","position":4,"cik":"0001906837","reported_name":"ARCH Venture Fund XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":5,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32071,"kind":"person","name":"GILLIS STEVEN","position":6,"cik":"0001229592","reported_name":"GILLIS STEVEN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32074,"kind":"person","name":"NELSEN ROBERT","position":7,"cik":"0001219042","reported_name":"NELSEN ROBERT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":8,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-09-20T10:16:19.000Z","date":"2023-09-19","kind":"exercise","planned":false,"acquired":true,"shares":1144973,"ownership":{"direct":false,"nature":"By ARCH Venture Fund VIII Overage, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of Series A-1 Preferred Stock, Series A-2 Preferred Stock and Series B Preferred Stock of the Issuer automatically converted on a 1-for-1 basis into Common Stock of the Issuer immediately prior to the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents shares held directly by ARCH Venture Fund VIII Overage, L.P. (ARCH VIII Overage). ARCH Venture Partners VIII, LLC (AVP VIII LLC) is the general partner of ARCH VIII Overage. Clinton Bybee, Keith Crandell and Robert Nelsen are the managing directors of AVP VIII LLC (the AVP VIII LLC Managing Directors). AVP VIII LLC may be deemed to beneficially own the shares held by ARCH VIII Overage, and each of the AVP VIII LLC Managing Directors may be deemed to share the power to direct the disposition and vote of the shares held by ARCH VIII Overage. Each of AVP VIII LLC and the AVP VIII LLC Managing Directors disclaims beneficial ownership except to the extent of their pecuniary interest therein, if any."}],"balance_after":1144973,"source":{"system":"sec-edgar","filing":"0000899243-23-019274","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1885522/000089924323019274/doc4.xml","form_type":"4"}},{"id":1776329,"issuer":{"id":6115,"kind":"organization","name":"Neumora Therapeutics, Inc."},"owners":[{"id":32128,"kind":"organization","name":"ARCH Venture Partners X, LLC","position":1,"cik":"0001769012","reported_name":"ARCH Venture Partners X, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50020,"kind":"organization","name":"ARCH Venture Partners XII, LLC","position":2,"cik":"0001979548","reported_name":"ARCH Venture Partners XII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50021,"kind":"organization","name":"ARCH Venture Partners XII, L.P.","position":3,"cik":"0001979765","reported_name":"ARCH Venture Partners XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":50022,"kind":"organization","name":"ARCH Venture Fund XII, L.P.","position":4,"cik":"0001906837","reported_name":"ARCH Venture Fund XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":5,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32071,"kind":"person","name":"GILLIS STEVEN","position":6,"cik":"0001229592","reported_name":"GILLIS STEVEN","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32074,"kind":"person","name":"NELSEN ROBERT","position":7,"cik":"0001219042","reported_name":"NELSEN ROBERT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":8,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-09-20T10:16:19.000Z","date":"2023-09-19","kind":"exercise","planned":false,"acquired":true,"shares":684167,"ownership":{"direct":false,"nature":"By ARCH Venture Fund VII, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of Series A-1 Preferred Stock, Series A-2 Preferred Stock and Series B Preferred Stock of the Issuer automatically converted on a 1-for-1 basis into Common Stock of the Issuer immediately prior to the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents shares held directly by ARCH Venture Fund VII, L.P. (ARCH VII). ARCH Venture Partners VII, L.P. (AVP VII LP) is the sole general partner of ARCH VII, and ARCH Venture Partners VII, LLC (AVP VII LLC) is the sole general partner of AVP VII LP. Clinton Bybee, Keith Crandell and Robert Nelsen are the managing directors of AVP VII LLC (AVP VII LLC Managing Directors). AVP VII LP and AVP VII LLC may be deemed to beneficially own the shares held by ARCH VII, and each of the AVP VII LLC Managing Directors may be deemed to share the power to direct the disposition and vote of the shares held by ARCH VII. Each of AVP VII LP, AVP VII LLC and the AVP VII LLC Managing Directors disclaims beneficial ownership except to the extent of their pecuniary interest therein, if any."}],"balance_after":684167,"source":{"system":"sec-edgar","filing":"0000899243-23-019274","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1885522/000089924323019274/doc4.xml","form_type":"4"}},{"id":2158259,"issuer":{"id":114958,"kind":"organization","name":"Codiak BioSciences, Inc.","symbol":"CDAK"},"owners":[{"id":123760,"kind":"organization","name":"ARCH Venture Fund VIII, L.P.","position":1,"cik":"0001605598","reported_name":"ARCH Venture Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73815,"kind":"organization","name":"ARCH Venture Fund VIII Overage, L.P.","position":2,"cik":"0001617237","reported_name":"ARCH Venture Fund VIII Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":3,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":4,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32074,"kind":"person","name":"NELSEN ROBERT","position":5,"cik":"0001219042","reported_name":"NELSEN ROBERT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73814,"kind":"organization","name":"ARCH Venture Partners VIII, LLC","position":6,"cik":"0001616165","reported_name":"ARCH Venture Partners VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":123761,"kind":"organization","name":"ARCH Venture Partners VIII, L.P.","position":7,"cik":"0001616176","reported_name":"ARCH Venture Partners VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2022-09-15T22:53:10.000Z","date":"2022-09-13","kind":"purchase","acquired":true,"shares":5000000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares purchased in a private investment in public equity transaction on September 13, 2022.  Accompanying the Common Stock is one Series A Warrant to purchase one share of common stock at an exercise price of $1.875 per share."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"Shares and warrants held by ARCH Venture Fund VIII, L.P. (\"ARCH Fund VIII\"). The sole general partner of ARCH Fund VIII is ARCH Venture Partners VIII, L.P. (\"ARCH Partners VIII\"), which may be deemed to beneficially own the shares and warrants held by ARCH Fund VIII. The sole general partner of ARCH Partners VIII is ARCH Venture Partners VIII, LLC (\"ARCH VIII LLC\"), which may be deemed to beneficially own the shares and warrants held by ARCH Fund VIII. ARCH Partners VIII and ARCH VIII LLC disclaim beneficial ownership of such shares and warrants, except to the extent of any pecuniary interest therein. The managing directors of ARCH VIII LLC are Keith L. Crandell, Clinton Bybee and Robert Nelsen, and they may be deemed to beneficially own the shares and warrants held by ARCH Fund VIII. Messrs. Crandell, Bybee and Nelsen disclaim beneficial ownership of such shares and warrants, except to the extent of any pecuniary interest therein."}],"balance_after":5000000,"derivative":{"exercise_price":1.875,"exercise_date":"2022-09-13","expiration_date":"2027-09-13","underlying":"Common Stock","underlying_shares":5000000},"source":{"system":"sec-edgar","filing":"0001062993-22-019586","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1219043/000106299322019586/form4.xml","form_type":"4"}},{"id":2158258,"issuer":{"id":114958,"kind":"organization","name":"Codiak BioSciences, Inc.","symbol":"CDAK"},"owners":[{"id":123760,"kind":"organization","name":"ARCH Venture Fund VIII, L.P.","position":1,"cik":"0001605598","reported_name":"ARCH Venture Fund VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73815,"kind":"organization","name":"ARCH Venture Fund VIII Overage, L.P.","position":2,"cik":"0001617237","reported_name":"ARCH Venture Fund VIII Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":3,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":4,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32074,"kind":"person","name":"NELSEN ROBERT","position":5,"cik":"0001219042","reported_name":"NELSEN ROBERT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":73814,"kind":"organization","name":"ARCH Venture Partners VIII, LLC","position":6,"cik":"0001616165","reported_name":"ARCH Venture Partners VIII, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":123761,"kind":"organization","name":"ARCH Venture Partners VIII, L.P.","position":7,"cik":"0001616176","reported_name":"ARCH Venture Partners VIII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Sotck","published_at":"2022-09-15T22:53:10.000Z","date":"2022-09-13","kind":"purchase","acquired":true,"shares":5000000,"price":1.5,"value":7500000.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares purchased in a private investment in public equity transaction on September 13, 2022.  Accompanying the Common Stock is one Series A Warrant to purchase one share of common stock at an exercise price of $1.875 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Comprised of 7,503,903 shares held by ARCH Venture Fund VIII, L.P. (\"ARCH Fund VIII\") and 1,350,195 shares held by ARCH Venture Fund VIII Overage, L.P. (\"ARCH Fund Overage\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares and warrants held by ARCH Venture Fund VIII, L.P. (\"ARCH Fund VIII\"). The sole general partner of ARCH Fund VIII is ARCH Venture Partners VIII, L.P. (\"ARCH Partners VIII\"), which may be deemed to beneficially own the shares and warrants held by ARCH Fund VIII. The sole general partner of ARCH Partners VIII is ARCH Venture Partners VIII, LLC (\"ARCH VIII LLC\"), which may be deemed to beneficially own the shares and warrants held by ARCH Fund VIII. ARCH Partners VIII and ARCH VIII LLC disclaim beneficial ownership of such shares and warrants, except to the extent of any pecuniary interest therein. The managing directors of ARCH VIII LLC are Keith L. Crandell, Clinton Bybee and Robert Nelsen, and they may be deemed to beneficially own the shares and warrants held by ARCH Fund VIII. Messrs. Crandell, Bybee and Nelsen disclaim beneficial ownership of such shares and warrants, except to the extent of any pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Shares held by ARCH Fund Overage.  The sole general partner of ARCH Fund Overage is ARCH VIII LLC, which may be deemed to beneficially own the shares held by ARCH Fund Overage. ARCH VIII LLC disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein. The managing directors of ARCH VIII LLC are Keith L. Crandell, Clinton Bybee and Robert Nelsen, and they may be deemed to beneficially own the shares held by ARCH Fund Overage. Messrs. Crandell, Bybee and Nelsen disclaim beneficial ownership of such shares, except to the extent of any pecuniary interest therein."}],"balance_after":8854098,"source":{"system":"sec-edgar","filing":"0001062993-22-019586","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1219043/000106299322019586/form4.xml","form_type":"4"}},{"id":2164170,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-09-08T00:29:00.000Z","date":"2022-09-06","kind":"other","acquired":true,"shares":3248,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Shares held by a trust for the benefit of family members of Bybee."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares held by a trust for the benefit of family members of Bybee."}],"balance_after":61160,"source":{"system":"sec-edgar","filing":"0001062993-22-019342","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322019342/form4.xml","form_type":"4"}},{"id":2164169,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-09-08T00:29:00.000Z","date":"2022-09-06","kind":"other","acquired":true,"shares":1624,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"Shares held directly by Bybee."}],"balance_after":30570,"source":{"system":"sec-edgar","filing":"0001062993-22-019342","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322019342/form4.xml","form_type":"4"}},{"id":2164168,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-09-08T00:29:00.000Z","date":"2022-09-06","kind":"other","acquired":true,"shares":14383,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Shares held directly by Crandell."}],"balance_after":272964,"source":{"system":"sec-edgar","filing":"0001062993-22-019342","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322019342/form4.xml","form_type":"4"}},{"id":2164167,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-09-08T00:29:00.000Z","date":"2022-09-06","kind":"other","acquired":false,"shares":310441,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are directly held by ARCH Venture Fund IX Overage, L.P. (\"ARCH Overage\"). ARCH Venture Partners IX Overage, L.P. (\"Overage GPLP\"), as the sole general partner of ARCH Overage, may be deemed to beneficially own the shares held by ARCH Overage. GPLLC, as the sole general partner of Overage GPLP, may be deemed to beneficially own the shares held by ARCH Overage. As managing directors of GPLLC, each of the ARCH Managing Directors may be deemed to beneficially own the shares held by ARCH Overage. Each of Overage GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any."}],"balance_after":7290655,"source":{"system":"sec-edgar","filing":"0001062993-22-019342","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322019342/form4.xml","form_type":"4"}},{"id":2164166,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-09-08T00:29:00.000Z","date":"2022-09-06","kind":"other","acquired":false,"shares":239559,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are directly held by ARCH Venture Fund IX, L.P. (\"ARCH IX\"). ARCH Venture Partners IX, L.P. (\"GPLP\"), as the sole general partner of ARCH IX, may be deemed to beneficially own the shares held by ARCH IX. ARCH Venture Partners IX, LLC (\"GPLLC\"), as the sole general partner of GPLP, may be deemed to beneficially own the shares held by ARCH IX. As managing directors of GPLLC, each of Keith Crandell and Clinton Bybee (the \"ARCH Managing Directors\"), may be deemed to beneficially own the shares held by ARCH IX. Each of GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any."}],"balance_after":5626008,"source":{"system":"sec-edgar","filing":"0001062993-22-019342","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322019342/form4.xml","form_type":"4"}},{"id":2164165,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-09-08T00:29:00.000Z","date":"2022-09-02","kind":"other","acquired":true,"shares":2662,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Shares held by a trust for the benefit of family members of Bybee."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares held by a trust for the benefit of family members of Bybee."}],"balance_after":57912,"source":{"system":"sec-edgar","filing":"0001062993-22-019342","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322019342/form4.xml","form_type":"4"}},{"id":2164164,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-09-08T00:29:00.000Z","date":"2022-09-02","kind":"other","acquired":true,"shares":1338,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"Shares held directly by Bybee."}],"balance_after":28946,"source":{"system":"sec-edgar","filing":"0001062993-22-019342","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322019342/form4.xml","form_type":"4"}},{"id":2164163,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-09-08T00:29:00.000Z","date":"2022-09-02","kind":"other","acquired":true,"shares":11763,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Shares held directly by Crandell."}],"balance_after":258581,"source":{"system":"sec-edgar","filing":"0001062993-22-019342","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322019342/form4.xml","form_type":"4"}},{"id":2164162,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-09-08T00:29:00.000Z","date":"2022-09-02","kind":"other","acquired":false,"shares":253997,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are directly held by ARCH Venture Fund IX Overage, L.P. (\"ARCH Overage\"). ARCH Venture Partners IX Overage, L.P. (\"Overage GPLP\"), as the sole general partner of ARCH Overage, may be deemed to beneficially own the shares held by ARCH Overage. GPLLC, as the sole general partner of Overage GPLP, may be deemed to beneficially own the shares held by ARCH Overage. As managing directors of GPLLC, each of the ARCH Managing Directors may be deemed to beneficially own the shares held by ARCH Overage. Each of Overage GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any."}],"balance_after":7601096,"source":{"system":"sec-edgar","filing":"0001062993-22-019342","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322019342/form4.xml","form_type":"4"}},{"id":2164161,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-09-08T00:29:00.000Z","date":"2022-09-02","kind":"other","acquired":false,"shares":196003,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are directly held by ARCH Venture Fund IX, L.P. (\"ARCH IX\"). ARCH Venture Partners IX, L.P. (\"GPLP\"), as the sole general partner of ARCH IX, may be deemed to beneficially own the shares held by ARCH IX. ARCH Venture Partners IX, LLC (\"GPLLC\"), as the sole general partner of GPLP, may be deemed to beneficially own the shares held by ARCH IX. As managing directors of GPLLC, each of Keith Crandell and Clinton Bybee (the \"ARCH Managing Directors\"), may be deemed to beneficially own the shares held by ARCH IX. Each of GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any."}],"balance_after":5865567,"source":{"system":"sec-edgar","filing":"0001062993-22-019342","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322019342/form4.xml","form_type":"4"}},{"id":2169009,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-09-01T21:20:33.000Z","date":"2022-08-31","kind":"other","acquired":true,"shares":2952,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Shares held by a trust for the benefit of family members of Bybee."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares held by a trust for the benefit of family members of Bybee."}],"balance_after":55250,"source":{"system":"sec-edgar","filing":"0001062993-22-018984","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018984/form4.xml","form_type":"4"}},{"id":2169008,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-09-01T21:20:33.000Z","date":"2022-08-31","kind":"other","acquired":true,"shares":1475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"Shares held directly by Bybee."}],"balance_after":27608,"source":{"system":"sec-edgar","filing":"0001062993-22-018984","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018984/form4.xml","form_type":"4"}},{"id":2169007,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-09-01T21:20:33.000Z","date":"2022-08-31","kind":"other","acquired":true,"shares":13076,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Shares held directly by Crandell."}],"balance_after":246818,"source":{"system":"sec-edgar","filing":"0001062993-22-018984","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018984/form4.xml","form_type":"4"}},{"id":2169006,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-09-01T21:20:33.000Z","date":"2022-08-31","kind":"other","acquired":false,"shares":282219,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are directly held by ARCH Venture Fund IX Overage, L.P. (\"ARCH Overage\"). ARCH Venture Partners IX Overage, L.P. (\"Overage GPLP\"), as the sole general partner of ARCH Overage, may be deemed to beneficially own the shares held by ARCH Overage. GPLLC, as the sole general partner of Overage GPLP, may be deemed to beneficially own the shares held by ARCH Overage. As managing directors of GPLLC, each of the ARCH Managing Directors may be deemed to beneficially own the shares held by ARCH Overage. Each of Overage GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any."}],"balance_after":7855093,"source":{"system":"sec-edgar","filing":"0001062993-22-018984","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018984/form4.xml","form_type":"4"}},{"id":2169005,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-09-01T21:20:33.000Z","date":"2022-08-31","kind":"other","acquired":false,"shares":217781,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are directly held by ARCH Venture Fund IX, L.P. (\"ARCH IX\"). ARCH Venture Partners IX, L.P. (\"GPLP\"), as the sole general partner of ARCH IX, may be deemed to beneficially own the shares held by ARCH IX. ARCH Venture Partners IX, LLC (\"GPLLC\"), as the sole general partner of GPLP, may be deemed to beneficially own the shares held by ARCH IX. As managing directors of GPLLC, each of Keith Crandell and Clinton Bybee (the \"ARCH Managing Directors\"), may be deemed to beneficially own the shares held by ARCH IX. Each of GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any."}],"balance_after":6061570,"source":{"system":"sec-edgar","filing":"0001062993-22-018984","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018984/form4.xml","form_type":"4"}},{"id":2169004,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-09-01T21:20:33.000Z","date":"2022-08-30","kind":"other","acquired":true,"shares":2952,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Shares held by a trust for the benefit of family members of Bybee."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares held by a trust for the benefit of family members of Bybee."}],"balance_after":52298,"source":{"system":"sec-edgar","filing":"0001062993-22-018984","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018984/form4.xml","form_type":"4"}},{"id":2169003,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-09-01T21:20:33.000Z","date":"2022-08-30","kind":"other","acquired":true,"shares":1475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"Shares held directly by Bybee."}],"balance_after":26133,"source":{"system":"sec-edgar","filing":"0001062993-22-018984","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018984/form4.xml","form_type":"4"}},{"id":2169002,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-09-01T21:20:33.000Z","date":"2022-08-30","kind":"other","acquired":true,"shares":13076,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Shares held directly by Crandell."}],"balance_after":233742,"source":{"system":"sec-edgar","filing":"0001062993-22-018984","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018984/form4.xml","form_type":"4"}},{"id":2169001,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-09-01T21:20:33.000Z","date":"2022-08-30","kind":"other","acquired":false,"shares":282219,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are directly held by ARCH Venture Fund IX Overage, L.P. (\"ARCH Overage\"). ARCH Venture Partners IX Overage, L.P. (\"Overage GPLP\"), as the sole general partner of ARCH Overage, may be deemed to beneficially own the shares held by ARCH Overage. GPLLC, as the sole general partner of Overage GPLP, may be deemed to beneficially own the shares held by ARCH Overage. As managing directors of GPLLC, each of the ARCH Managing Directors may be deemed to beneficially own the shares held by ARCH Overage. Each of Overage GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any."}],"balance_after":8137312,"source":{"system":"sec-edgar","filing":"0001062993-22-018984","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018984/form4.xml","form_type":"4"}},{"id":2169000,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-09-01T21:20:33.000Z","date":"2022-08-30","kind":"other","acquired":false,"shares":217781,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are directly held by ARCH Venture Fund IX, L.P. (\"ARCH IX\"). ARCH Venture Partners IX, L.P. (\"GPLP\"), as the sole general partner of ARCH IX, may be deemed to beneficially own the shares held by ARCH IX. ARCH Venture Partners IX, LLC (\"GPLLC\"), as the sole general partner of GPLP, may be deemed to beneficially own the shares held by ARCH IX. As managing directors of GPLLC, each of Keith Crandell and Clinton Bybee (the \"ARCH Managing Directors\"), may be deemed to beneficially own the shares held by ARCH IX. Each of GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any."}],"balance_after":6279351,"source":{"system":"sec-edgar","filing":"0001062993-22-018984","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018984/form4.xml","form_type":"4"}},{"id":2172908,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-26T21:12:30.000Z","date":"2022-08-25","kind":"other","acquired":true,"shares":2952,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Shares held by a trust for the benefit of family members of Bybee."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares held by a trust for the benefit of family members of Bybee."}],"balance_after":49346,"source":{"system":"sec-edgar","filing":"0001062993-22-018811","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018811/form4.xml","form_type":"4"}},{"id":2172907,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-26T21:12:30.000Z","date":"2022-08-25","kind":"other","acquired":true,"shares":1475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"Shares held directly by Bybee."}],"balance_after":24658,"source":{"system":"sec-edgar","filing":"0001062993-22-018811","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018811/form4.xml","form_type":"4"}},{"id":2172906,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-26T21:12:30.000Z","date":"2022-08-25","kind":"other","acquired":true,"shares":13076,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Shares held directly by Crandell."}],"balance_after":220666,"source":{"system":"sec-edgar","filing":"0001062993-22-018811","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018811/form4.xml","form_type":"4"}},{"id":2172905,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-26T21:12:30.000Z","date":"2022-08-25","kind":"other","acquired":false,"shares":282219,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are directly held by ARCH Venture Fund IX Overage, L.P. (\"ARCH Overage\"). ARCH Venture Partners IX Overage, L.P. (\"Overage GPLP\"), as the sole general partner of ARCH Overage, may be deemed to beneficially own the shares held by ARCH Overage. GPLLC, as the sole general partner of Overage GPLP, may be deemed to beneficially own the shares held by ARCH Overage. As managing directors of GPLLC, each of the ARCH Managing Directors may be deemed to beneficially own the shares held by ARCH Overage. Each of Overage GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any."}],"balance_after":8419531,"source":{"system":"sec-edgar","filing":"0001062993-22-018811","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018811/form4.xml","form_type":"4"}},{"id":2172904,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-26T21:12:30.000Z","date":"2022-08-25","kind":"other","acquired":false,"shares":217781,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are directly held by ARCH Venture Fund IX, L.P. (\"ARCH IX\"). ARCH Venture Partners IX, L.P. (\"GPLP\"), as the sole general partner of ARCH IX, may be deemed to beneficially own the shares held by ARCH IX. ARCH Venture Partners IX, LLC (\"GPLLC\"), as the sole general partner of GPLP, may be deemed to beneficially own the shares held by ARCH IX. As managing directors of GPLLC, each of Keith Crandell and Clinton Bybee (the \"ARCH Managing Directors\"), may be deemed to beneficially own the shares held by ARCH IX. Each of GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any."}],"balance_after":6497132,"source":{"system":"sec-edgar","filing":"0001062993-22-018811","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018811/form4.xml","form_type":"4"}},{"id":2172903,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-26T21:12:30.000Z","date":"2022-08-24","kind":"other","acquired":true,"shares":2952,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Shares held by a trust for the benefit of family members of Bybee."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares held by a trust for the benefit of family members of Bybee."}],"balance_after":46394,"source":{"system":"sec-edgar","filing":"0001062993-22-018811","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018811/form4.xml","form_type":"4"}},{"id":2172902,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-26T21:12:30.000Z","date":"2022-08-24","kind":"other","acquired":true,"shares":1475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"Shares held directly by Bybee."}],"balance_after":23183,"source":{"system":"sec-edgar","filing":"0001062993-22-018811","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018811/form4.xml","form_type":"4"}},{"id":2172901,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-26T21:12:30.000Z","date":"2022-08-24","kind":"other","acquired":true,"shares":13076,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Shares held directly by Crandell."}],"balance_after":207590,"source":{"system":"sec-edgar","filing":"0001062993-22-018811","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018811/form4.xml","form_type":"4"}},{"id":2172900,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-26T21:12:30.000Z","date":"2022-08-24","kind":"other","acquired":false,"shares":282219,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are directly held by ARCH Venture Fund IX Overage, L.P. (\"ARCH Overage\"). ARCH Venture Partners IX Overage, L.P. (\"Overage GPLP\"), as the sole general partner of ARCH Overage, may be deemed to beneficially own the shares held by ARCH Overage. GPLLC, as the sole general partner of Overage GPLP, may be deemed to beneficially own the shares held by ARCH Overage. As managing directors of GPLLC, each of the ARCH Managing Directors may be deemed to beneficially own the shares held by ARCH Overage. Each of Overage GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any."}],"balance_after":8701750,"source":{"system":"sec-edgar","filing":"0001062993-22-018811","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018811/form4.xml","form_type":"4"}},{"id":2172899,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-26T21:12:30.000Z","date":"2022-08-24","kind":"other","acquired":false,"shares":217781,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are directly held by ARCH Venture Fund IX, L.P. (\"ARCH IX\"). ARCH Venture Partners IX, L.P. (\"GPLP\"), as the sole general partner of ARCH IX, may be deemed to beneficially own the shares held by ARCH IX. ARCH Venture Partners IX, LLC (\"GPLLC\"), as the sole general partner of GPLP, may be deemed to beneficially own the shares held by ARCH IX. As managing directors of GPLLC, each of Keith Crandell and Clinton Bybee (the \"ARCH Managing Directors\"), may be deemed to beneficially own the shares held by ARCH IX. Each of GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any."}],"balance_after":6714913,"source":{"system":"sec-edgar","filing":"0001062993-22-018811","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018811/form4.xml","form_type":"4"}},{"id":2177037,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-22T21:14:32.000Z","date":"2022-08-18","kind":"other","acquired":true,"shares":2952,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Shares held by a trust for the benefit of family members of Bybee."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares held by a trust for the benefit of family members of Bybee."}],"balance_after":43442,"source":{"system":"sec-edgar","filing":"0001062993-22-018573","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018573/form4.xml","form_type":"4"}},{"id":2177036,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-22T21:14:32.000Z","date":"2022-08-18","kind":"other","acquired":true,"shares":1475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"Shares held directly by Bybee."}],"balance_after":21708,"source":{"system":"sec-edgar","filing":"0001062993-22-018573","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018573/form4.xml","form_type":"4"}},{"id":2177035,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-22T21:14:32.000Z","date":"2022-08-18","kind":"other","acquired":true,"shares":13076,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Shares held directly by Crandell."}],"balance_after":194514,"source":{"system":"sec-edgar","filing":"0001062993-22-018573","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018573/form4.xml","form_type":"4"}},{"id":2177034,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-22T21:14:32.000Z","date":"2022-08-18","kind":"other","acquired":false,"shares":282219,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are directly held by ARCH Venture Fund IX Overage, L.P. (\"ARCH Overage\"). ARCH Venture Partners IX Overage, L.P. (\"Overage GPLP\"), as the sole general partner of ARCH Overage, may be deemed to beneficially own the shares held by ARCH Overage. GPLLC, as the sole general partner of Overage GPLP, may be deemed to beneficially own the shares held by ARCH Overage. As managing directors of GPLLC, each of the ARCH Managing Directors may be deemed to beneficially own the shares held by ARCH Overage. Each of Overage GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any."}],"balance_after":8983969,"source":{"system":"sec-edgar","filing":"0001062993-22-018573","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018573/form4.xml","form_type":"4"}},{"id":2177033,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-22T21:14:32.000Z","date":"2022-08-18","kind":"other","acquired":false,"shares":217781,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are directly held by ARCH Venture Fund IX, L.P. (\"ARCH IX\"). ARCH Venture Partners IX, L.P. (\"GPLP\"), as the sole general partner of ARCH IX, may be deemed to beneficially own the shares held by ARCH IX. ARCH Venture Partners IX, LLC (\"GPLLC\"), as the sole general partner of GPLP, may be deemed to beneficially own the shares held by ARCH IX. As managing directors of GPLLC, each of Keith Crandell and Clinton Bybee (the \"ARCH Managing Directors\"), may be deemed to beneficially own the shares held by ARCH IX. Each of GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any."}],"balance_after":6932694,"source":{"system":"sec-edgar","filing":"0001062993-22-018573","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018573/form4.xml","form_type":"4"}},{"id":2184280,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-17T01:04:59.000Z","date":"2022-08-16","kind":"other","acquired":true,"shares":2952,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Shares held by a trust for the benefit of family members of Bybee."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares held by a trust for the benefit of family members of Bybee."}],"balance_after":40490,"source":{"system":"sec-edgar","filing":"0001062993-22-018154","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018154/form4.xml","form_type":"4"}},{"id":2184279,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-17T01:04:59.000Z","date":"2022-08-16","kind":"other","acquired":true,"shares":1475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"Shares held directly by Bybee."}],"balance_after":20233,"source":{"system":"sec-edgar","filing":"0001062993-22-018154","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018154/form4.xml","form_type":"4"}},{"id":2184278,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-17T01:04:59.000Z","date":"2022-08-16","kind":"other","acquired":true,"shares":13076,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Shares held directly by Crandell."}],"balance_after":181438,"source":{"system":"sec-edgar","filing":"0001062993-22-018154","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018154/form4.xml","form_type":"4"}},{"id":2184277,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-17T01:04:59.000Z","date":"2022-08-16","kind":"other","acquired":false,"shares":282219,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are directly held by ARCH Venture Fund IX Overage, L.P. (\"ARCH Overage\"). ARCH Venture Partners IX Overage, L.P. (\"Overage GPLP\"), as the sole general partner of ARCH Overage, may be deemed to beneficially own the shares held by ARCH Overage. GPLLC, as the sole general partner of Overage GPLP, may be deemed to beneficially own the shares held by ARCH Overage. As managing directors of GPLLC, each of the ARCH Managing Directors may be deemed to beneficially own the shares held by ARCH Overage. Each of Overage GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any."}],"balance_after":9266188,"source":{"system":"sec-edgar","filing":"0001062993-22-018154","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018154/form4.xml","form_type":"4"}},{"id":2184276,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-17T01:04:59.000Z","date":"2022-08-16","kind":"other","acquired":false,"shares":217781,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are directly held by ARCH Venture Fund IX, L.P. (\"ARCH IX\"). ARCH Venture Partners IX, L.P. (\"GPLP\"), as the sole general partner of ARCH IX, may be deemed to beneficially own the shares held by ARCH IX. ARCH Venture Partners IX, LLC (\"GPLLC\"), as the sole general partner of GPLP, may be deemed to beneficially own the shares held by ARCH IX. As managing directors of GPLLC, each of Keith Crandell and Clinton Bybee (the \"ARCH Managing Directors\"), may be deemed to beneficially own the shares held by ARCH IX. Each of GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any."}],"balance_after":7150475,"source":{"system":"sec-edgar","filing":"0001062993-22-018154","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018154/form4.xml","form_type":"4"}},{"id":2184275,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-17T01:04:59.000Z","date":"2022-08-15","kind":"other","acquired":true,"shares":2952,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Shares held by a trust for the benefit of family members of Bybee."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares held by a trust for the benefit of family members of Bybee."}],"balance_after":37538,"source":{"system":"sec-edgar","filing":"0001062993-22-018154","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018154/form4.xml","form_type":"4"}},{"id":2184274,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-17T01:04:59.000Z","date":"2022-08-15","kind":"other","acquired":true,"shares":1475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"Shares held directly by Bybee."}],"balance_after":18758,"source":{"system":"sec-edgar","filing":"0001062993-22-018154","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018154/form4.xml","form_type":"4"}},{"id":2184273,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-17T01:04:59.000Z","date":"2022-08-15","kind":"other","acquired":true,"shares":13076,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Shares held directly by Crandell."}],"balance_after":168362,"source":{"system":"sec-edgar","filing":"0001062993-22-018154","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018154/form4.xml","form_type":"4"}},{"id":2184272,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-17T01:04:59.000Z","date":"2022-08-15","kind":"other","acquired":false,"shares":282219,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are directly held by ARCH Venture Fund IX Overage, L.P. (\"ARCH Overage\"). ARCH Venture Partners IX Overage, L.P. (\"Overage GPLP\"), as the sole general partner of ARCH Overage, may be deemed to beneficially own the shares held by ARCH Overage. GPLLC, as the sole general partner of Overage GPLP, may be deemed to beneficially own the shares held by ARCH Overage. As managing directors of GPLLC, each of the ARCH Managing Directors may be deemed to beneficially own the shares held by ARCH Overage. Each of Overage GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any."}],"balance_after":9548407,"source":{"system":"sec-edgar","filing":"0001062993-22-018154","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018154/form4.xml","form_type":"4"}},{"id":2184271,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-17T01:04:59.000Z","date":"2022-08-15","kind":"other","acquired":false,"shares":217781,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are directly held by ARCH Venture Fund IX, L.P. (\"ARCH IX\"). ARCH Venture Partners IX, L.P. (\"GPLP\"), as the sole general partner of ARCH IX, may be deemed to beneficially own the shares held by ARCH IX. ARCH Venture Partners IX, LLC (\"GPLLC\"), as the sole general partner of GPLP, may be deemed to beneficially own the shares held by ARCH IX. As managing directors of GPLLC, each of Keith Crandell and Clinton Bybee (the \"ARCH Managing Directors\"), may be deemed to beneficially own the shares held by ARCH IX. Each of GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any."}],"balance_after":7368256,"source":{"system":"sec-edgar","filing":"0001062993-22-018154","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018154/form4.xml","form_type":"4"}},{"id":2184270,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-17T01:04:59.000Z","date":"2022-08-12","kind":"other","acquired":true,"shares":2952,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Shares held by a trust for the benefit of family members of Bybee."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Shares held by a trust for the benefit of family members of Bybee."}],"balance_after":34586,"source":{"system":"sec-edgar","filing":"0001062993-22-018154","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018154/form4.xml","form_type":"4"}},{"id":2184269,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-17T01:04:59.000Z","date":"2022-08-12","kind":"other","acquired":true,"shares":1475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"Shares held directly by Bybee."}],"balance_after":17283,"source":{"system":"sec-edgar","filing":"0001062993-22-018154","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018154/form4.xml","form_type":"4"}},{"id":2184268,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-17T01:04:59.000Z","date":"2022-08-12","kind":"other","acquired":true,"shares":13076,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Shares held directly by Crandell."}],"balance_after":155286,"source":{"system":"sec-edgar","filing":"0001062993-22-018154","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018154/form4.xml","form_type":"4"}},{"id":2184267,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-17T01:04:59.000Z","date":"2022-08-12","kind":"other","acquired":false,"shares":282219,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are directly held by ARCH Venture Fund IX Overage, L.P. (\"ARCH Overage\"). ARCH Venture Partners IX Overage, L.P. (\"Overage GPLP\"), as the sole general partner of ARCH Overage, may be deemed to beneficially own the shares held by ARCH Overage. GPLLC, as the sole general partner of Overage GPLP, may be deemed to beneficially own the shares held by ARCH Overage. As managing directors of GPLLC, each of the ARCH Managing Directors may be deemed to beneficially own the shares held by ARCH Overage. Each of Overage GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any."}],"balance_after":9830626,"source":{"system":"sec-edgar","filing":"0001062993-22-018154","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018154/form4.xml","form_type":"4"}},{"id":2184266,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-17T01:04:59.000Z","date":"2022-08-12","kind":"other","acquired":false,"shares":217781,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are directly held by ARCH Venture Fund IX, L.P. (\"ARCH IX\"). ARCH Venture Partners IX, L.P. (\"GPLP\"), as the sole general partner of ARCH IX, may be deemed to beneficially own the shares held by ARCH IX. ARCH Venture Partners IX, LLC (\"GPLLC\"), as the sole general partner of GPLP, may be deemed to beneficially own the shares held by ARCH IX. As managing directors of GPLLC, each of Keith Crandell and Clinton Bybee (the \"ARCH Managing Directors\"), may be deemed to beneficially own the shares held by ARCH IX. Each of GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any."}],"balance_after":7586037,"source":{"system":"sec-edgar","filing":"0001062993-22-018154","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322018154/form4.xml","form_type":"4"}},{"id":2236059,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-06-11T01:27:15.000Z","date":"2022-06-08","kind":"other","acquired":true,"shares":2952,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Reclassified shares previously reported as direct to indirect to reflect these shares are held by a trust for the benefit of family members of Bybee."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Reclassified shares previously reported as direct to indirect to reflect these shares are held by a trust for the benefit of family members of Bybee."}],"balance_after":31634,"source":{"system":"sec-edgar","filing":"0001062993-22-014696","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322014696/form4.xml","form_type":"4"}},{"id":2236058,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-06-11T01:27:15.000Z","date":"2022-06-08","kind":"other","acquired":true,"shares":1475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Reclassified shares previously reported as direct to indirect to reflect these shares are held by a trust for the benefit of family members of Bybee."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"Shares held directly by Bybee."}],"balance_after":15808,"source":{"system":"sec-edgar","filing":"0001062993-22-014696","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322014696/form4.xml","form_type":"4"}},{"id":2236057,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-06-11T01:27:15.000Z","date":"2022-06-08","kind":"other","acquired":true,"shares":13076,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Shares held directly by Crandell."}],"balance_after":142210,"source":{"system":"sec-edgar","filing":"0001062993-22-014696","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322014696/form4.xml","form_type":"4"}},{"id":2236056,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-06-11T01:27:15.000Z","date":"2022-06-08","kind":"other","acquired":false,"shares":282219,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are directly held by ARCH Venture Fund IX Overage, L.P. (\"ARCH Overage\"). ARCH Venture Partners IX Overage, L.P. (\"Overage GPLP\"), as the sole general partner of ARCH Overage, may be deemed to beneficially own the shares held by ARCH Overage. GPLLC, as the sole general partner of Overage GPLP, may be deemed to beneficially own the shares held by ARCH Overage. As managing directors of GPLLC, each of the ARCH Managing Directors may be deemed to beneficially own the shares held by ARCH Overage. Each of Overage GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any."}],"balance_after":10112845,"source":{"system":"sec-edgar","filing":"0001062993-22-014696","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322014696/form4.xml","form_type":"4"}},{"id":2236055,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-06-11T01:27:15.000Z","date":"2022-06-08","kind":"other","acquired":false,"shares":217781,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are directly held by ARCH Venture Fund IX, L.P. (\"ARCH IX\"). ARCH Venture Partners IX, L.P. (\"GPLP\"), as the sole general partner of ARCH IX, may be deemed to beneficially own the shares held by ARCH IX. ARCH Venture Partners IX, LLC (\"GPLLC\"), as the sole general partner of GPLP, may be deemed to beneficially own the shares held by ARCH IX. As managing directors of GPLLC, each of Keith Crandell and Clinton Bybee (the \"ARCH Managing Directors\"), may be deemed to beneficially own the shares held by ARCH IX. Each of GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any."}],"balance_after":7803818,"source":{"system":"sec-edgar","filing":"0001062993-22-014696","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322014696/form4.xml","form_type":"4"}},{"id":2242432,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-06-07T00:24:33.000Z","date":"2022-06-02","kind":"other","acquired":true,"shares":4426,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"Shares held directly by Bybee."}],"balance_after":43015,"source":{"system":"sec-edgar","filing":"0001062993-22-014426","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322014426/form4.xml","form_type":"4"}},{"id":2242431,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-06-07T00:24:33.000Z","date":"2022-06-02","kind":"other","acquired":true,"shares":13076,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Shares held directly by Crandell."}],"balance_after":129134,"source":{"system":"sec-edgar","filing":"0001062993-22-014426","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322014426/form4.xml","form_type":"4"}},{"id":2242430,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-06-07T00:24:33.000Z","date":"2022-06-02","kind":"other","acquired":false,"shares":282219,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are directly held by ARCH Venture Fund IX Overage, L.P. (\"ARCH Overage\"). ARCH Venture Partners IX Overage, L.P. (\"Overage GPLP\"), as the sole general partner of ARCH Overage, may be deemed to beneficially own the shares held by ARCH Overage. GPLLC, as the sole general partner of Overage GPLP, may be deemed to beneficially own the shares held by ARCH Overage. As managing directors of GPLLC, each of the ARCH Managing Directors may be deemed to beneficially own the shares held by ARCH Overage. Each of Overage GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any."}],"balance_after":10395064,"source":{"system":"sec-edgar","filing":"0001062993-22-014426","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322014426/form4.xml","form_type":"4"}},{"id":2242429,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-06-07T00:24:33.000Z","date":"2022-06-02","kind":"other","acquired":false,"shares":217781,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are directly held by ARCH Venture Fund IX, L.P. (\"ARCH IX\"). ARCH Venture Partners IX, L.P. (\"GPLP\"), as the sole general partner of ARCH IX, may be deemed to beneficially own the shares held by ARCH IX. ARCH Venture Partners IX, LLC (\"GPLLC\"), as the sole general partner of GPLP, may be deemed to beneficially own the shares held by ARCH IX. As managing directors of GPLLC, each of Keith Crandell and Clinton Bybee (the \"ARCH Managing Directors\"), may be deemed to beneficially own the shares held by ARCH IX. Each of GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any."}],"balance_after":8021599,"source":{"system":"sec-edgar","filing":"0001062993-22-014426","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299322014426/form4.xml","form_type":"4"}},{"id":2461100,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-12-22T22:59:59.000Z","date":"2021-12-20","kind":"other","acquired":true,"shares":15504,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"Shares held directly by Bybee."}],"balance_after":38589,"source":{"system":"sec-edgar","filing":"0001062993-21-013385","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299321013385/form4.xml","form_type":"4"}},{"id":2461099,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-12-22T22:59:59.000Z","date":"2021-12-20","kind":"other","acquired":true,"shares":45703,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Shares held directly by Crandell."}],"balance_after":116058,"source":{"system":"sec-edgar","filing":"0001062993-21-013385","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299321013385/form4.xml","form_type":"4"}},{"id":2461098,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-12-22T22:59:59.000Z","date":"2021-12-20","kind":"other","acquired":false,"shares":987767,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are directly held by ARCH Venture Fund IX Overage, L.P. (\"ARCH Overage\"). ARCH Venture Partners IX Overage, L.P. (\"Overage GPLP\"), as the sole general partner of ARCH Overage, may be deemed to beneficially own the shares held by ARCH Overage. GPLLC, as the sole general partner of Overage GPLP, may be deemed to beneficially own the shares held by ARCH Overage. As managing directors of GPLLC, each of the ARCH Managing Directors may be deemed to beneficially own the shares held by ARCH Overage. Each of Overage GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any."}],"balance_after":10677283,"source":{"system":"sec-edgar","filing":"0001062993-21-013385","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299321013385/form4.xml","form_type":"4"}},{"id":2461097,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-12-22T22:59:59.000Z","date":"2021-12-20","kind":"other","acquired":false,"shares":762233,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are directly held by ARCH Venture Fund IX, L.P. (\"ARCH IX\"). ARCH Venture Partners IX, L.P. (\"GPLP\"), as the sole general partner of ARCH IX, may be deemed to beneficially own the shares held by ARCH IX. ARCH Venture Partners IX, LLC (\"GPLLC\"), as the sole general partner of GPLP, may be deemed to beneficially own the shares held by ARCH IX. As managing directors of GPLLC, each of Keith Crandell and Clinton Bybee (the \"ARCH Managing Directors\"), may be deemed to beneficially own the shares held by ARCH IX. Each of GPLP, GPLLC and the ARCH Managing Directors disclaims beneficial ownership of the securities reported herein, except to the extent of their pecuniary interest therein, if any."}],"balance_after":8239380,"source":{"system":"sec-edgar","filing":"0001062993-21-013385","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299321013385/form4.xml","form_type":"4"}},{"id":2490760,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-12-01T23:30:38.000Z","date":"2021-11-29","kind":"other","acquired":true,"shares":4428,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F6","text":"Shares held directly by Bybee."}],"balance_after":23085,"source":{"system":"sec-edgar","filing":"0001062993-21-011917","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299321011917/form4.xml","form_type":"4"}},{"id":2490759,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":32127,"kind":"organization","name":"ARCH Venture Partners IX, LLC","position":1,"cik":"0001723174","reported_name":"ARCH Venture Partners IX, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32124,"kind":"organization","name":"ARCH Venture Partners IX, L.P.","position":2,"cik":"0001723173","reported_name":"ARCH Venture Partners IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32125,"kind":"organization","name":"ARCH Venture Partners IX Overage, L.P.","position":3,"cik":"0001723172","reported_name":"ARCH Venture Partners IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32121,"kind":"organization","name":"ARCH Venture Fund IX, L.P.","position":4,"cik":"0001666306","reported_name":"ARCH Venture Fund IX, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32122,"kind":"organization","name":"ARCH Venture Fund IX Overage, L.P.","position":5,"cik":"0001666307","reported_name":"ARCH Venture Fund IX Overage, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32072,"kind":"person","name":"CRANDELL KEITH","position":6,"cik":"0001219039","reported_name":"CRANDELL KEITH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":32073,"kind":"person","name":"BYBEE CLINTON","position":7,"cik":"0001219043","reported_name":"BYBEE CLINTON","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-12-01T23:30:38.000Z","date":"2021-11-29","kind":"other","acquired":true,"shares":13057,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Distribution of Common Stock held by a limited partnership to its partners for no consideration."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F5","text":"Shares held directly by Crandell."}],"balance_after":70355,"source":{"system":"sec-edgar","filing":"0001062993-21-011917","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000106299321011917/form4.xml","form_type":"4"}}],"next_cursor":"2021-12-01T23:30:38.000000Z,2490759"}